白藜芦醇对TNF-α诱导的RAFLS抗增殖抗炎作用及其调节PI3K/Akt信号通路的研究
|
摘要
目的：观察白藜芦醇(Res)对TNF-α诱导类风湿关节炎成纤维样滑膜细胞(RA FLS)增殖及凋亡的影响,以及其对促凋亡因子Bcl-x1／Bcl-2相关死亡启动子(BAD)的作用,探讨Res对TNF-α诱导的RAFLS作用机制。
方法：滑膜组织取自行膝关节置换术的活动性类风湿关节炎患者6例,分离出成纤维样滑膜细胞进行原代培养及鉴定。不同浓度的Res干预RA FLS后再用TNF-α(10ng.ml-1)刺激24h。MTT比色法测定Res对TNF-α诱导RA FLS生长的抑制作用。流式细胞仪检测法Res对RA FLS细胞周期及凋亡率的影响。Western-blot方法分析Res对TNF-α诱导RA FLS中磷酸化BAD蛋白表达的影响。
结果：低浓度(12.5μM、25μM) Res对TNF-α诱导RA FLS增殖无明显的抑制作用,当Res浓度为50-200μM时,对TNF-α诱导RA FLS增殖具有明显抑制作用(P＜0.05),并呈时间和剂量依赖性。低浓度(12.5μM、25μM)Res对TNF-α诱导RA FLS细胞周期无影响,50-200μMRes对RA FLS细胞周期的影响表现为DNA合成前期的细胞(G1期)比例增加,DNA合成期(S期)细胞比例减少,DNA合成后期和分裂期(G2／M期)细胞比例亦减少。随着Res浓度增大,RA FLS增殖指数逐渐降低,并呈剂量依赖性。低浓度Res (12.5、25μM)组凋亡细胞百分比分别为(1.95±0.62)%、(2.37±0.76)%,与TNF-α组((1.52±0.73)%)比较,差异均没有统计学意义(P>0.05)；较高浓度Res(50、100、200μM)组凋亡细胞百分比分别为(5.92±1.23)%、(9.06±1.78)%、(12.26±3.01)%,随着Res浓度增高,凋亡细胞数增加,与TNF-a组比较,有显著性差异(P＜0.05)。TNF-α刺激RA FLS后,磷酸化BAD表达明显增加,当用不同浓度的Res干预后,磷酸化BAD表达减少,呈剂量依赖关系。
结论：50-200μM Res通过阻滞RA FLS细胞周期,降低BAD磷酸化水平发挥抑制TNF-α诱导RA FLS增殖,促凋亡作用,Res具有治疗RA的潜在价值。
目的：观察Res对TNF-α诱导的RAFLS主要炎性细胞因子IL-1β、MMP3产生的影响,从炎性细胞因子的角度来探讨Res的抗炎作用。
方法：ELISA法检测各组细胞上清液中IL-1β、MMP-3的含量,逆转录-聚合酶链式反应(RT-PCR)检测TNF-α诱导的FLS中IL-1β、MMP-3的mRNA表达,Western-blot方法分析Res对TNF-α诱导RA FLS中IL-1β、MMP-3蛋白表达的影响。
结果：在TNF-α刺激24h后,RA FLS上清液IL-1β、MMP-3的含量急剧升高,分别为(436.235±79.721)pg.ml-1, (89.950±14.458)ng.ml-1,与空白组比较,有显著性差异(P<0.01)。Res抑制TNF-α诱导RA FLS分泌IL-1β、MMP-3,呈剂量依赖性。Res在浓度为12.5μM时即可抑制TNF-α诱导RA FLS的IL-1β、MMP-3mRNA的表达水平,至100、200μM时抑制作用达到最高峰。Western-blot方法分析显示Res呈剂量依赖关系降低TNF-α诱导RA FLS中IL-1β、MMP-3的蛋白表达。
结论：Res在mRNA和蛋白质水平抑制TNF-α诱导的RA FLS的IL-1β、MMP-3分泌,Res通过抑制细胞因子的产生发挥抗炎作用。
目的：观察PI3K/Akt信号通路在TNF-α诱导RA FLS增殖及炎性因子产生中的作用,以及Res对TNF-α诱导RA FLS的PI3K/Akt信号通路影响,探讨Res对TNF-α诱导RA FLS发挥抗增殖及抗炎作用的分子机理。
方法：间接免疫荧光细胞化学染色法检测RA FLS各组磷酸化Akt蛋白表达。Western-blot方法检测PI3K抑制剂LY294002 (20μM)对TNF-α诱导RA FLS中磷酸化BAD、IL-1β、MMP-3蛋白表达的影响以及Res对TNF-α诱导RA FLS中Akt、磷酸化Akt蛋白表达的作用。
结果：荧光显微镜下观察RA FLS细胞,磷酸化Akt蛋白在TNF-Q组表达增强,而在空白组、LY294002组,磷酸化Akt蛋白基本没有表达,50μMRes组较TNF-α组,磷酸化Akt蛋白表达明显降低。Western-blot方法分析显示LY294002下调TNF-α诱导磷酸化BAD及炎性因子IL-1β、MMP3蛋白表达水平。50-200μM Res可显著降低TNF-Q诱导RA FLS磷酸化Akt蛋白水平,并呈剂量依赖关系。
结论：TNF-α诱导的RA FLS增殖及IL-1β、MMP-3产生中存在PI3K/Akt信号通路的激活,LY294002可以阻断这一效应。50-200μMRes可降低Akt磷酸化水平,下调磷酸化BAD及IL-1β、MMP-3蛋白表达,抑制RA FLS增殖,发挥促凋亡及抗炎作用；Res可能在类风湿关节炎的治疗方面具有良好的临床应用前景。
Objective To observe the effect of resveratrol (Res) on in vitro TNF-a-induced proliferation and apoptosis of human rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS), and further to investigate the effect of Res on the Bcl-2-associated death promoter (BAD) for the mechanism.
Methods Synovial tisssues were obtained from patients with active RA according to the revised criteria of the American College of Rheumatology,who were undergoing knee joint replacement. RA FLS were stimulated with TNF-α(10ng.ml-1) for 24h in the presence or absence of resveratrol.The inhibition rate of RA FLS was examined by MTT assay. Cell cycle and the amount of apoptotic cells was measured by flow cytometry. Phosphorylated BAD protein expression was measured by western blot.
Results In the lower concentration 12.5μM、25μM) of Res group, TNF-α-induced proliferation,cell phase and the apoptosis ratio of RA FLS have no obvious effections compared to TNF-a group (p>0.05), However in higher concentration(50μM、100μM、200μM), the living cells measured by MTT dose and time-dependently reduced, and the fraction of living cells in the S-phase and G2/M-phase decreased respectively, while that in G1-phase increased, the difference was statistically significant compared with the TNF-a group(P< 0.05).Flow cytometry demonstrated that the apoptosis rate increased in a dose-dependent manner among the higher concentration of Res groups. Higher concentration Res inhibited dose-dependently TNF-α-induced phosphorylation of BAD in RA FLS.
Conclusions Higher concentration (50-200MM) Res can inhibit TNF-a-induced proliferation and induce apoptosis of RA FLS through blocking cell cycle and inhibition of BAD phosphorylation. Res may provide a new therapeutic approach in the treatment of RA.
Objective To Observe the inhibition of Res on TNF-a-induced production of mainly inflammatory cytokines such as IL-1β、MMP3 in RA FLS, and further to explore the anti-inflammatory effects of Res from the perspective of inflammatory cytokines.
Methods The levels of IL-1β、MMP-3 in cultural supernatants among groups were measured by enzyme-linked immunosorbent assay (ELISA). Messenger RNA expression of IL-1βand MMP-3 in RA FLS induced by TNF-a were analyzed using a reverse transcription-polymerase chain reaction (RT-PCR). Western-blot analysis was used to detect the expression of IL-1βand MMP-3 in RA FLS intervened by Res.
Results After stimulating with TNF-a for 24h, the levels of IL-1βMMP-3 sharply increased in cultural supernatants of RA FLS, respectively(436.235±79.721)pg.ml-1, (89.950±14.458)ng.ml-1, contrast to blank group(P<0.05). Res inhibited TNF-a-induced production of IL-1βand MMP-3 on RA FLS in a dose-dependent manner. Res at concentration of 12.5μM can immediately inhibited the mRNAs expression of IL-1βand MMP-3, while going to the concentration of 100,200μM, inhibitions of Res reached a peak. The Western-blot analysis showed that Res inhibited TNF-α-induced proteins expression of IL-1βand MMP-3 on RA FLS in a dose-dependent manner.
Conclusions Res inhibited TNF-α-induced secretion of IL-1βand MMP-3 in RA FLS on both the mRNA and the protein level. Res plays an anti-inflammatory role via preventing cytokines production.
Objective To evaluate the role of PI3K/Akt signaling pathway in TNF-a-induced proliferation and production of proinflammatory cytokines on RA FLS, and the modulation of Res on PI3K/Akt signaling pathway, further to exploring the anti-inflammatory and anti-proliferative effects of Res for its molecular mechanism.
Methods Indirect immunofluorescence staining was used to detect the expression of phosphorylated Akt among RA FLS groups. The proteins expression of phosphorylated BAD、IL-1β、MMP-3、phosphorylated Akt and Akt were examined by Western-blot method.
Results Immunofluorescence staining showed that the expression of phosphorylated Akt increased significantly in TNF-αgroup, while there were no obvious expression of phosphorylated Akt both in blank group and PI3K inhibitor LY294002 group. However lower expression of phosphorylated Akt was seen in 50μMRes group compared with TNF-αgroup. The Western-blot method showed the PI3K inhibitor LY294002 decreased the proteins expression of TNF-α-induced phosphorylated BAD and IL-1βMMP-3. Higher concentration Res (50-200μM) also decreased significantly the expression of phosphorylated Akt dose-dependently.
Conclusions Activation of PI3K/Akt signaling pathway exists in TNF-α-induced proliferation and production of IL-1β、MMP3 on RA FLS, which is hampered by LY294002.Res can reduce the expression of phosphorylated BAD and IL-1β、MMP-3 through inhibition of Akt phosphorylation. Res exerts an anti-proliferative and anti-inflammatory effects in TNF-α-induced RA FLS, indicating Res may have good clinical application prospect in the treatment of rheumatoid arthritis.
方法：滑膜组织取自行膝关节置换术的活动性类风湿关节炎患者6例,分离出成纤维样滑膜细胞进行原代培养及鉴定。不同浓度的Res干预RA FLS后再用TNF-α(10ng.ml-1)刺激24h。MTT比色法测定Res对TNF-α诱导RA FLS生长的抑制作用。流式细胞仪检测法Res对RA FLS细胞周期及凋亡率的影响。Western-blot方法分析Res对TNF-α诱导RA FLS中磷酸化BAD蛋白表达的影响。
结果：低浓度(12.5μM、25μM) Res对TNF-α诱导RA FLS增殖无明显的抑制作用,当Res浓度为50-200μM时,对TNF-α诱导RA FLS增殖具有明显抑制作用(P＜0.05),并呈时间和剂量依赖性。低浓度(12.5μM、25μM)Res对TNF-α诱导RA FLS细胞周期无影响,50-200μMRes对RA FLS细胞周期的影响表现为DNA合成前期的细胞(G1期)比例增加,DNA合成期(S期)细胞比例减少,DNA合成后期和分裂期(G2／M期)细胞比例亦减少。随着Res浓度增大,RA FLS增殖指数逐渐降低,并呈剂量依赖性。低浓度Res (12.5、25μM)组凋亡细胞百分比分别为(1.95±0.62)%、(2.37±0.76)%,与TNF-α组((1.52±0.73)%)比较,差异均没有统计学意义(P>0.05)；较高浓度Res(50、100、200μM)组凋亡细胞百分比分别为(5.92±1.23)%、(9.06±1.78)%、(12.26±3.01)%,随着Res浓度增高,凋亡细胞数增加,与TNF-a组比较,有显著性差异(P＜0.05)。TNF-α刺激RA FLS后,磷酸化BAD表达明显增加,当用不同浓度的Res干预后,磷酸化BAD表达减少,呈剂量依赖关系。
结论：50-200μM Res通过阻滞RA FLS细胞周期,降低BAD磷酸化水平发挥抑制TNF-α诱导RA FLS增殖,促凋亡作用,Res具有治疗RA的潜在价值。
目的：观察Res对TNF-α诱导的RAFLS主要炎性细胞因子IL-1β、MMP3产生的影响,从炎性细胞因子的角度来探讨Res的抗炎作用。
方法：ELISA法检测各组细胞上清液中IL-1β、MMP-3的含量,逆转录-聚合酶链式反应(RT-PCR)检测TNF-α诱导的FLS中IL-1β、MMP-3的mRNA表达,Western-blot方法分析Res对TNF-α诱导RA FLS中IL-1β、MMP-3蛋白表达的影响。
结果：在TNF-α刺激24h后,RA FLS上清液IL-1β、MMP-3的含量急剧升高,分别为(436.235±79.721)pg.ml-1, (89.950±14.458)ng.ml-1,与空白组比较,有显著性差异(P<0.01)。Res抑制TNF-α诱导RA FLS分泌IL-1β、MMP-3,呈剂量依赖性。Res在浓度为12.5μM时即可抑制TNF-α诱导RA FLS的IL-1β、MMP-3mRNA的表达水平,至100、200μM时抑制作用达到最高峰。Western-blot方法分析显示Res呈剂量依赖关系降低TNF-α诱导RA FLS中IL-1β、MMP-3的蛋白表达。
结论：Res在mRNA和蛋白质水平抑制TNF-α诱导的RA FLS的IL-1β、MMP-3分泌,Res通过抑制细胞因子的产生发挥抗炎作用。
目的：观察PI3K/Akt信号通路在TNF-α诱导RA FLS增殖及炎性因子产生中的作用,以及Res对TNF-α诱导RA FLS的PI3K/Akt信号通路影响,探讨Res对TNF-α诱导RA FLS发挥抗增殖及抗炎作用的分子机理。
方法：间接免疫荧光细胞化学染色法检测RA FLS各组磷酸化Akt蛋白表达。Western-blot方法检测PI3K抑制剂LY294002 (20μM)对TNF-α诱导RA FLS中磷酸化BAD、IL-1β、MMP-3蛋白表达的影响以及Res对TNF-α诱导RA FLS中Akt、磷酸化Akt蛋白表达的作用。
结果：荧光显微镜下观察RA FLS细胞,磷酸化Akt蛋白在TNF-Q组表达增强,而在空白组、LY294002组,磷酸化Akt蛋白基本没有表达,50μMRes组较TNF-α组,磷酸化Akt蛋白表达明显降低。Western-blot方法分析显示LY294002下调TNF-α诱导磷酸化BAD及炎性因子IL-1β、MMP3蛋白表达水平。50-200μM Res可显著降低TNF-Q诱导RA FLS磷酸化Akt蛋白水平,并呈剂量依赖关系。
结论：TNF-α诱导的RA FLS增殖及IL-1β、MMP-3产生中存在PI3K/Akt信号通路的激活,LY294002可以阻断这一效应。50-200μMRes可降低Akt磷酸化水平,下调磷酸化BAD及IL-1β、MMP-3蛋白表达,抑制RA FLS增殖,发挥促凋亡及抗炎作用；Res可能在类风湿关节炎的治疗方面具有良好的临床应用前景。
Objective To observe the effect of resveratrol (Res) on in vitro TNF-a-induced proliferation and apoptosis of human rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS), and further to investigate the effect of Res on the Bcl-2-associated death promoter (BAD) for the mechanism.
Methods Synovial tisssues were obtained from patients with active RA according to the revised criteria of the American College of Rheumatology,who were undergoing knee joint replacement. RA FLS were stimulated with TNF-α(10ng.ml-1) for 24h in the presence or absence of resveratrol.The inhibition rate of RA FLS was examined by MTT assay. Cell cycle and the amount of apoptotic cells was measured by flow cytometry. Phosphorylated BAD protein expression was measured by western blot.
Results In the lower concentration 12.5μM、25μM) of Res group, TNF-α-induced proliferation,cell phase and the apoptosis ratio of RA FLS have no obvious effections compared to TNF-a group (p>0.05), However in higher concentration(50μM、100μM、200μM), the living cells measured by MTT dose and time-dependently reduced, and the fraction of living cells in the S-phase and G2/M-phase decreased respectively, while that in G1-phase increased, the difference was statistically significant compared with the TNF-a group(P< 0.05).Flow cytometry demonstrated that the apoptosis rate increased in a dose-dependent manner among the higher concentration of Res groups. Higher concentration Res inhibited dose-dependently TNF-α-induced phosphorylation of BAD in RA FLS.
Conclusions Higher concentration (50-200MM) Res can inhibit TNF-a-induced proliferation and induce apoptosis of RA FLS through blocking cell cycle and inhibition of BAD phosphorylation. Res may provide a new therapeutic approach in the treatment of RA.
Objective To Observe the inhibition of Res on TNF-a-induced production of mainly inflammatory cytokines such as IL-1β、MMP3 in RA FLS, and further to explore the anti-inflammatory effects of Res from the perspective of inflammatory cytokines.
Methods The levels of IL-1β、MMP-3 in cultural supernatants among groups were measured by enzyme-linked immunosorbent assay (ELISA). Messenger RNA expression of IL-1βand MMP-3 in RA FLS induced by TNF-a were analyzed using a reverse transcription-polymerase chain reaction (RT-PCR). Western-blot analysis was used to detect the expression of IL-1βand MMP-3 in RA FLS intervened by Res.
Results After stimulating with TNF-a for 24h, the levels of IL-1βMMP-3 sharply increased in cultural supernatants of RA FLS, respectively(436.235±79.721)pg.ml-1, (89.950±14.458)ng.ml-1, contrast to blank group(P<0.05). Res inhibited TNF-a-induced production of IL-1βand MMP-3 on RA FLS in a dose-dependent manner. Res at concentration of 12.5μM can immediately inhibited the mRNAs expression of IL-1βand MMP-3, while going to the concentration of 100,200μM, inhibitions of Res reached a peak. The Western-blot analysis showed that Res inhibited TNF-α-induced proteins expression of IL-1βand MMP-3 on RA FLS in a dose-dependent manner.
Conclusions Res inhibited TNF-α-induced secretion of IL-1βand MMP-3 in RA FLS on both the mRNA and the protein level. Res plays an anti-inflammatory role via preventing cytokines production.
Objective To evaluate the role of PI3K/Akt signaling pathway in TNF-a-induced proliferation and production of proinflammatory cytokines on RA FLS, and the modulation of Res on PI3K/Akt signaling pathway, further to exploring the anti-inflammatory and anti-proliferative effects of Res for its molecular mechanism.
Methods Indirect immunofluorescence staining was used to detect the expression of phosphorylated Akt among RA FLS groups. The proteins expression of phosphorylated BAD、IL-1β、MMP-3、phosphorylated Akt and Akt were examined by Western-blot method.
Results Immunofluorescence staining showed that the expression of phosphorylated Akt increased significantly in TNF-αgroup, while there were no obvious expression of phosphorylated Akt both in blank group and PI3K inhibitor LY294002 group. However lower expression of phosphorylated Akt was seen in 50μMRes group compared with TNF-αgroup. The Western-blot method showed the PI3K inhibitor LY294002 decreased the proteins expression of TNF-α-induced phosphorylated BAD and IL-1βMMP-3. Higher concentration Res (50-200μM) also decreased significantly the expression of phosphorylated Akt dose-dependently.
Conclusions Activation of PI3K/Akt signaling pathway exists in TNF-α-induced proliferation and production of IL-1β、MMP3 on RA FLS, which is hampered by LY294002.Res can reduce the expression of phosphorylated BAD and IL-1β、MMP-3 through inhibition of Akt phosphorylation. Res exerts an anti-proliferative and anti-inflammatory effects in TNF-α-induced RA FLS, indicating Res may have good clinical application prospect in the treatment of rheumatoid arthritis.
引文
[1]Noss EH, Brenner MB. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis.Immunol Rev.2008; 223:252-270.
[2]奚正德,李宁丽,张雁云等.滑膜成纤维细胞在关节炎发病中的作用.自然杂志,2004；26(4)：205-208.
[3]Harris SJ, Foster JG, Ward SG. PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies.Curr Opin Investig Drugs.2009;10(11):1151-1162.
[4]Marone R, Cmiljanovic V, Giese B,et al. Targeting phosphoinositide 3-kinase:moving towards therapy. Biochim Biophys Acta.2008;1784(1):159-185.
[5]苏君梅.Akt与肿瘤的关系及其作用机制的研究进展.杭州师范学院学报(医学版),2008；2(4)：272-274.
[6]Reedquist KA, Ludikhuize J, Tak PP. Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis.Biochem Soc Trans.2006;34:727-730.
[7]Montecucco F, Steffens S, Burger F,et al. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD 18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-lalpha) on human neutrophils through defined signalling pathways. Cell Signal. 2008;20(3):557-568.
[8]Ferrandi C, Ardissone V, Ferro P, et al. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther.2007;322(3):923-930.
[9]Kim KW, Cho ML, Park MK,et al.Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther.2005;7(1):R139-148.
[10]Choi YA, Lim HK, Kim JR, et al. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem.2004;27;279(35):36579-36585.
[11]Wenink MH, Santegoets KC, Roelofs MF, et al.The inhibitory Fc gamma Ⅱb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.J Immunol.2009, 1;183(7):4509-4520.
[12]Chiu YC, Lin CY, Chen CP,et al. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway.J Immunol. 2009;15,183(4):2785-2792.
[13]Westra J, Brouwer E, Bos R, et al.Regulation of cytokine-induced HIF-lalpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci.2007;1108:340-348.
[14]Forough R,WeylieB,Collins C, et al. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo:role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.J Vasc Res.2006; 43(4):327-337.
[15]Park CM,Park MJ, Kwak HJ,etal.Ionizing radiation enbancemmtfix metalloproteinase-2 secretion and invasion of glioma cells through src/epidennal growth factor receptor-mediated p38 /Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res,2006,66(17): 8511-8519.
[16]Hayer S, Pundt N, Peters MA, etal.PI3Kγ regulates cartilage damage in chronic inflammatory arthritis, The FASEB Journal.2009;23:4288-4298.
[17]]Wu T, Mohan C. The AKT axis as a therapeutic target in autoimmune diseases.Endocr Metab Immune Disord Drug Targets.2009;9(2):145-150.
[18]Harikumar KB, Aggarwal BB. Resveratrol:a multitargeted agent for age-associated chronic diseases.Cell Cycle.2008,15;7(8):1020-1035.
[19]朱青,韩苏夏,马瑾璐.白藜芦醇抗肿瘤活性研究进展.,现代肿瘤医学,2006,14(5)：634-636.
[20]Fr6jdo S, Cozzone D, Vidal H,et al. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J.2007; 15;406(3):511-518.
[21]Khanna D, Sethi G, Ahn KS, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol.2007;7(3):344-351.
[22]Tang LL, Gao JS, Chen XR, et al. Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheumatoid arthritis and its mechanism in vitro.Zhong Nan Da Xue Xue Bao Yi Xue Ban.2006;31(4):528-533.
[23]唐玲丽,高洁生,陈新瑞.白藜芦醇体外诱导类风湿关节炎滑膜细胞凋亡的实验研究.中南药学,2006,(4)4：245-248.
[24]唐玲丽,余平,田静等。类风湿关节炎滑膜细胞凋亡过程中白藜芦醇的诱导作用及天冬氨酸特异性半胱氨酸蛋白酶3的活化.中国临床康复,2005,9(23)：142-144.
[25]Byun HS, Song JK, Kim YR.et al. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes Rheumatol 2008;47:301-308.
[26]杜金烽,高洁生,陈进伟等.白藜芦醇对大鼠佐剂性关节炎的抗炎作用及对抗胶原Ⅱ抗体的影响。中华风湿病杂志,2009,13(2)：123-126.
[1]Garcia S, Bodano A, Pablos JL, et al. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts. Ann Rheum Dis ,2008;67:631-637
[2]Yoo SA, Park BH, Park GS, et al. Calcineurin Is Expressed and Plays a Critical Role in Inflammatory Arthritis.J Immunol,2006; 177:2681-2690.
[3]黄世峰,肖长虹,顾为望等.人类风湿性关节炎B型滑膜细胞的分离、培养和纯化.广东医学,2007,28(2)：197-199.
[4]蒋建平,朱志刚,易朝辉等.人关节滑膜A型和B型细胞的纯化分离和体外培养.解放军医学杂志2001,26(5)：387-388.
[5]刘晓燕,谢华福,宋杰等.人滑膜细胞体外培养的比较研究.泸州医学院学报,2005,(6)：510-512.
[6]彭卫华,侯凡凡,蒋建平等.改良的胶原酶滑膜细胞分离培养法.第一军医大学学报,2000,20(5)：469-470.
[7]舒强,李兴福,刘花香等.类风湿关节炎滑膜成纤维样细胞增殖特性的体外研究.山东大学学报(医学版),2006,11(44)：1095-1099.
[8]Lehmann J, JungelA, Lehmann I, et al. Grafting of fibroblasts isolated from the synovial membrane of rheumatoid arthritis (RA) patients induces chronic arthritis in SCID mice-A novel model for studying the arthritogenic role of RA fibroblasts in vivo. J Autoimmun,2000,15 (3):301-313.
[9]史战国,朱平,卢宁等.类风湿关节炎成纤维样滑膜细胞的表型及其侵蚀软骨的特性.细胞与分子免疫学杂志,2006,22(4)：493-495.
[10]Harikumar KB, Aggarwal BB. Resveratrol:a multitargeted agent for age-associated chronic diseases. Cell Cycle,2008,15;7(8):1020-1035.
[11]朱青,韩苏夏,马瑾璐.白藜芦醇抗肿瘤活性研究进展.现代肿瘤医学,2006,14(5)：634-636.
[12]Clement MV, Hirpara JL, Chawdhury SH, etal.Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells.Blood,1998,92 (3):996-1002.
[13]KuoPL,ChiangLC,LinCC. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in HepG2 cells. Life Sci,2002,72 (1):23-24.
[14]ShihA,DavisFB,LinHY,et al. Resveratrol induces apoptosis in thyroid cancer cell lines via MAPK-and-p53-dependent mechanism.Clin Endocrinol Metab,2002,87 (3):1223-1232.
[15]AttenMJ,AttarBM,MilsonT,et al. Resveratrol-induced inactivation of human gastricaden ocarcinoma cells through a proteinkinaseC-mediated mechanism. Biochem Pharmacol,2001,62 (10):1423-1432.
[16]RomanV,BillardC; KernC,et al. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukemia. BrJ Haematol,2002,117 (4):842-851.
[17]Latruffe N, Nelmas D, Jannin B, et al. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent. Int J Mol Med,2002; 10 (6):755-760.
[18]于良,孙中杰,吴胜利等.白藜芦醇对小鼠移植性肝癌组织中细胞周期蛋白的影响.第四军医大学学报,2002；23(23)：2172-2174.
[19]朱青,张王刚,王立锋等.白藜芦醇诱导肿瘤细胞凋亡和细胞周期阻滞的作用及机制。第四军医大学学报,2005；26(21)1935-1937.
[20]Adhami VM, Afaq F, Ahmad N. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.Biochem Biophys Res Commun,2001,288(3):579-585.
[21]Atten MJ, Godoy-RomeroE,Attar BM, et al. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells[J].Invest New Drugs,2005,23(2):111-119.
[22]Castello L, Tessitore L. Resveratrol inhibits cell cycle progression in U937cells [J].Oncol Rep,2005,13(1):133-137.
[23]Chen Y, Tseng SH, Lai HS, et al. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice[J].Surgery.2004,16(1):57-66.
[24]田雪梅,张展霞.白藜芦醇促进Ca2+介导的线粒体通透转变孔道开放.药学学报,2003,38(2)：81-84.
[25]Mouria M,Gukovskays AS, Juang Y,et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome crelease and apoptosis.Int J Cancer,2002,98(5):761-769.
[26]ZiGang Dong.Molecular mechanism of the chemopreventive effect of resveratorl. Mutation Research,2003,(523-524):145-150.
[27]冯骥良,温巧莲,何伟玲等。白藜芦醇以caspase依赖和非依赖两种方式导致Jurkat细胞死亡细胞生物学杂志,2007,29：103-108.
[28]唐旭东,周克元,陈小文等.白藜芦醇诱导鼻咽癌细胞CNE-2Z凋亡过程中caspase-6的活化。中国免疫学杂志,2003(19)2：100-103.
[29]唐旭东,周克元,丁航.白藜芦醇诱导CNE-2Z细胞凋亡过程中caspase-3的活化.免疫学杂志,2003(19)1：23-29.
[30]郝春燕,苏海翔,魏虎来等.白藜芦醇通过Fas依赖途径诱导K562细胞凋亡.实用癌症杂志,2004,19(6)：561-563.
[31]Nakagawa H, Kiyozuka Y, Uemura YJ,et al. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. Cancer Res Clin Oncol.2001;127(4):258-264.
[32]孙春艳,胡豫,刘新月等.白藜芦醇对多发性骨髓瘤细胞的体外抗癌作用.中草药,2007,38(1)：80-84.
[33]林江,藏宁,陶红等.bcl-2和bax及NF-kB在白藜芦醇诱导肝癌细胞凋亡中的作用.中国微生态学杂志,2005；17(3)：164-165.
[34]Tang LL, Gao JS, Chen XR, et al. Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheumatoid arthritis and its mechanism in vitro.Zhong Nan Da Xue Xue Bao Yi Xue Ban.2006;31(4):528-533.
[35]唐玲丽,高洁生,陈新瑞.白藜芦醇体外诱导类风湿关节炎滑膜细胞凋亡的实验研究。中南药学,2006,(4)4：245-248.
[36]唐玲丽,余平,田静等.类风湿关节炎滑膜细胞凋亡过程中白藜芦醇的诱导作用及天冬氨酸特异性半胱氨酸蛋白酶3的活化.中国临床康复,2005,9(23)：142-144.
[37]Byun HS, Song JK, Kim YR.et al. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes Rheumatol,2008;47:301-308.
[38]Niquet J, Wasterlain CG. Bim, Bad,and Bax:a deadly combination in epileptic seizures[J]. J Clin Invest,2004,113(7):960-962.
[39]Pettipher ER,Higgs GA,Henderson B.Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.Proc Natl Acad Sci USA,1986,83:8749-8753.
[40]Sun HB, Nalim R, Yokota H1 Exp ression and axtivities of matrix metallop roteinases under oscillatory shear in IL-1 stimulated synovial cuesl Connect Tissue Res,2003,44(1):42-49.
[41]Ribbens C, Andre B, Kaye O, et al. Synovial fluid matrixmetallop roteinase-3 levels are increased in inflammatory arthritiswhether erosive or not. J Rheumatol,2000,39 (12):1357-1365.
[42]Kane D, Jensen L, Grehan S, et al.Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage pannus junctionl J Rheumatol,2004,31 (7):1274-1280.
[43]Kamphuis S, Hrafnkelsdottir K, Klein MR, et al. Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.Arthritis Res Ther,2006,8 (6):R178.
[44]Canu V, Goldberg R, Peppard J, et al. Inhibition of interleukin-1αinduced cartilage by matrix protein degradation in bovine articular by matrix metalloproteinases in the generation of cartilage oligomeirix protein fragments in arthritic synovial fluid[J]. Arthritis Rheum,1998,41 (12):2143-2151.
[45]Boscolo P, del Signore A, Sabbioni E et al. Effects of resveratrol on lymphocyte proliferation and cytokine release.Ann Clin Lab Sci.2003;33(2):226-231.
[46]Zhong M, Cheng GF, Wang WJ, etal. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice.Phytomedicine.1999;6(2):79-84.
[47]Culpitt SV, Rogers DF, Fenwick PS,et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.Thorax.2003;58(11):942-946.
[48]Kang OH, Jang HJ, Chae HS, et al. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells:pivotal roles of NF-kappaB and MAPK.Pharmacol Res.2009;59(5):330-337.
[49]Shakibaei M, Csaki C, Nebrich S, et al. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes:potential for use as a novel nutraceutical for the treatment of osteoarthritis.Biochem Pharmacol.2008;76(11):1426-1439.
[50]Banerjee S, Bueso Ramas C, Aggarwal BB. Suppression of 7,12 dimethybenz(a) anthracene-induced mammary carcinogenesis in rats by resveratrol:rule of nuclear factor-kappB, cyclooxygenase 2, and matrix metalloprotrase 9 [J]. Cancer Res,2002,62 (17):4945-4954
[51]李怡棠,沈放,白金叶等.地塞米松、吲哚美辛和白藜芦醇对巴豆油致炎小鼠耳部基质金属酶-9的抑制作用[J].药学学报,2003,28(7)：501
[52]葛恒,张俊峰,郭炳诗等.白藜芦醇抑制巨噬细胞外基质金属蛋白酶诱导物表达。药学学报,2006,41(7)：625-630.
[53]Cao Y, Fu ZD, Wang F, et al.Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants.J Asian Nat Prod Res.2005;7(3):205-213
[54]Harris SJ, Foster JG, Ward SG.PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies.Curr Opin Investig Drugs.2009;10(11):1151-1162.
[55]Marone R, Cmiljanovic V, Giese B,et al. Biochim Biophys Acta. Targeting phosphoinositide 3-kinase:moving towards therapy.2008;1784(1):159-185.
[56]苏君梅.Akt与肿瘤的关系及其作用机制的研究进展.杭州师范学院学报(医学版),2008,28(4)：272-274.
[57]Reedquist KA, Ludikhuize J, Tak PP. Phosphoinositide 3-kinase signalling and FoxO transcrip-tion factors in rheumatoid arthritis.Biochem Soc Trans.2006;34:727-730.
[58]Montecucco F, Steffens S, Burger F,et al. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CDllb/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1 alpha) on human neutrophils through defined signalling pathways. Cell Signal. 2008;20(3):557-568.
[59]Ferrandi C, Ardissone V, Ferro P, et al. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther.2007,322(3):923-930.
[60]Wenink MH, Santegoets KC, Roelofs MF, et al.The inhibitory Fc gamma Ⅱb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.J Immunol,.2009, 1;183(7):4509-4520.
[61]Chiu YC, Lin CY, Chen CP,et al. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway.J Immunol. 2009;183(4):2785-2792.
[62]Westra J, Brouwer E, Bos R, et al.Regulation of cytokine-induced HIF-lalpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci.2007;1108:340-348.
[63]Hayer S, Pundt N, Peters MA, etal.PI3Kγregulates cartilage damage in chronic inflammatory arthritis,The FASEB Journal.2009;23:4288-4298.
[64]]Wu T, Mohan C. The AKT axis as a therapeutic target in autoimmune diseases.Endocr Metab Immune Disord Drug Targets.2009;9(2):145-150.
[65]Frojd6 S, Cozzone D, Vidal H,et al. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J.2007,15;406(3):511-518.
[66]Xu H,He Y,Yang X, et al.Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.Rheumatology,2007;46 (6):920-926.
[67]Kim HR, Cho ML, Kim KW, et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways.Rheumatology,2007;46 (1):57-64.
[68]Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al.Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem,2001,70:535-602
[69]Rommel C, Camps M, Ji H.PI3K delta and PI3K gamma:partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol.2007; 7(3):191-201.
[70]Sale EM, Hodgkinsen CP, Jones NP, et al.A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNKIand ATP citratelyase[J].Biochemistry,2006,45(I):213-223.
[71]Zhang HG, Wang Y, Xie JF, et al.Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum 2001;44(7):1555-1567.
[72]Morel J, Audo R, Hahne M, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem.2005;280(16):15709-15718.
[73]Kim G, Jun JB, Elkon KB.Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts.Arthritis Rheum.2002;46(6):1504-1511.
[74]Sasaki T, Irie-Sasaki J, Jones RG, et al. Function of PI3K7 in thymocyte development, T cell activation, and neutrophil migration. Science 2000,287,1040-1046.
[75]Li Z, Jiang H, Xie W, et al.. Roles of PLC-β2 and-β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science,2000:287,1046-1049
[76]Hirsch E, Katanaev VL, Garlanda C,et al. Central role for G protein-coupled phosphoinositide 3-kinase in inflammation. Science 2000,287,1049-1053
[77]Camps M, Ruckle T, Ji H, et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med.2005,11,936-943.
[78]Randis TM, Puri KD, Zhou H,et al. Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils. Eur J Immunol.2008,38,1215-1224.
[79]Yoo JK, Kwon H, Khil LY, et al.IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways.J Immunol. 2005,175(12):8280-8286.
[80]Forough R,WeylieB,Collins C, et al. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo:role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.J Vasc Res.2006; 43(4):327-337.
[81]Wang K, Scheel-Toellner D,et al. Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways.J Immunol.2003;171(2):1035-1041.
[82]王聪华,陈丽娜,朱平等。CD147分子通过VEGF促进类风湿关节炎滑膜组织中的血管新生。细胞与分子免疫学杂志。2007,23(5)：426-428.
[83]Miyashita T,Kawakami A,Tamai M, et al. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoprosis inducing ligand mediated apoptosis in rheumatoid synovial cells. Biochem Biophys Res Commun,2003,312 (2):397-404.
[84]Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM.Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer.2004 20;109(2):167-173.
[1]Harikumar KB, Aggarwal BB. Resveratrol:a multitargeted agent for age-associated chronic diseases.Cell Cycle.2008,15;7(8):1020-1035.
[2]朱青,韩苏夏,马瑾璐.白藜芦醇抗肿瘤活性研究进展.现代肿瘤医学,2006,14(5)：634-636。
[3]Khanna D, Sethi G, Ahn KS, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol.2007;7(3):344-351.
[4]傅喆暾,张蓉,黄宝康等天然植物中活性成分白藜芦醇的作用研究进展.现代中药研究与实践.2005,19(2)：62-64。
[5]Bertelli A,Bertelli AA, Gozzini A,et al. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res.1998.24:133-138.
[6]Fremont, L. Biological effects of resveratrol. Life Sci.2000,66(8):663-673.
[7]赵克森.白藜芦醇的一般生物学作用,国外医学卫生学分册,2002, (6)：374-376.
[8]Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratr-ol to rats for 28days is not harmful[J].J Nutr,2002,132(2):257-260.
[9]钟芳,罗少军,汤少明.白藜芦醇抑制细胞增殖研究新进展.中草药,2003,34,(5)附2-4.
[10]付丽华,胡玉红，孙盛等.白藜芦醇抗肿瘤作用的研究进展.黑龙江医药科学,2006,29(6)：98-100.
[11]Fontecave M, Lepoivre M, Elleingand E,et al. Resveratrol, a remarkable inhibitor of ribonucle-otide reductase. FEBS Lett.1998,16;421(3):277-279.
[12]Sun NJ, Woo SH, Cassady JM, Snapka RM.DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia.J Nat Prod.1998;61(3):362-366.
[13]Latruffe N, Nelmas D, Jannin B, et al. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent [J].Int J Mol Med,2002;10 (6):755-760.
[14]于良,孙中杰,吴胜利等.白藜芦醇对小鼠移植性肝癌组织中细胞周期蛋白的影响[J].第四军医大学学报,2002；23(23)：2172-2174.
[15]朱青,张王刚,王立锋等.白藜芦醇诱导肿瘤细胞凋亡和细胞周期阻滞的作用及机制.第四军医大学学报,2005；26(21)：1935-1937.
[16]Adhami VM, Afaq F, Ahmad N Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.Biochem Biophys Res Commun,2001,288(3):579-585
[17]Atten MJ, Godoy-RomeroE,Attar BM, et al. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells[J].Invest New Drugs,2005,23(2):111-119.
[18]Castello L, Tessitore L. Resveratrol inhibits cell cycle progression in U937cells [J].Oncol Rep,2005,13(1):133-137.
[19]Chen Y, Tseng SH, Lai HS, et al. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice[J].Surgery.2004,16(1):57-66.
[20]Fuggetta MP, Lanzilli G, Tricarico M, et al.Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.J Exp Clin Cancer Res.2006;25(2):189-193.
[21]Lanzilli G, Fuggetta MP, Tricarico M, et al.Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol.2006;28(3):641-648.
[22]田雪梅,张展霞.白藜芦醇促进Ca2+介导的线粒体通透转变孔道开放.药学学报,(2)：81-84。
[23]Mouria M,Gukovskays AS, Juang Y,et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochromecrelease and apoptosis[J].Int J Cancer,2002,98(5):761-769.
[24]Nakagawa H, Kiyozuka Y, Uemura YJ,et al. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. Cancer Res Clin Oncol.2001;127(4):258-264.
[25]孙春艳,胡豫,刘新月等.白藜芦醇对多发性骨髓瘤细胞的体外抗癌作用.中草药,2007,38(1)：80-84.
[26]林江,藏宁,陶红等.bcl-2和bax及NF-kB在白藜芦醇诱导肝癌细胞凋亡中的作用.中国微生态学杂志.2005,17(3)：164-165.
[27]唐旭东,周克元,陈小文等.白藜芦醇诱导鼻咽癌细胞CNE-2Z凋亡过程中caspase-6的活化。中国免疫学杂志,2003：(19)2：100-103.
[28]唐旭东,周克元,丁航.白藜芦醇诱导CNE-2Z细胞凋亡过程中caspase-3的活化.免疫学杂志，2003；(19)1：23-29.
[29]ZiGang Dong.Molecular mechanism of the chemopreventive effect of resveratorl[J]. Mutation Research,2003, (523-524):145-150.
[30]胜利,安利峰,何烨等.白藜芦醇抑制胆囊癌细胞生长与诱导细胞凋亡的实验研究.中药材 2005,28(6)：489-491
[31]冯骥良,温巧莲,何伟玲等.白藜芦醇以caspase依赖和非依赖两种方式导致Jurkat细胞死亡.细胞生物学杂志,2007,29：103-108.
[32]Clement MV, Hirpara JL, Chawdhury SH, etal.Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells.Blood,1998;92 (3):996-1002.
[33]郝春燕,苏海翔,魏虎来等.白藜芦醇通过Fas依赖途径诱导K562细胞凋亡。实用癌症杂志,2004,19(6)：561-563.
[34]Tang LL, Gao JS, Chen XR, et al. Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheumatoid arthritis and its mechanism in vitro.Zhong Nan Da Xue Xue Bao Yi Xue Ban.2006;31(4):528-533.
[35]唐玲丽,高洁生,陈新瑞.白藜芦醇体外诱导类风湿关节炎滑膜细胞凋亡的实验研究.中南药学,2006,(4)4：245-248.
[36]唐玲丽,余平,田静等.类风湿关节炎滑膜细胞凋亡过程中白藜芦醇的诱导作用及天冬氨酸特异性半胱氨酸蛋白酶3的活化.中国临床康复,2005,9(23)：142-144.
[37]Byun HS, Song JK, Kim YR.et al. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. Rheumatol,2008;47:301-308.
[38]Falchetti R, Fuggeta MP, Lanzili G,et al.Effects of resveratrol on human immune cell function[J].Life Science,2001,70:81-96.
[39]Xiao HuaGao,Dorrah Deeb, Joseph M edia,et a l.Immunodulatory activity of resveratol: discrepant in vitro and in vivo immunological effects[J].Biochem Pharmacol,2003,66:2427-2435.
[40]高路,袁育康,吕卓人等.白藜芦醇的免疫调节作用.西安交通大学学报(医学版),2003,24(2)：121-123.
[41]于良,吴胜利,张梅等.白藜芦醇及与环抱菌素A联用对人外周血T细胞免疫功能的影响[J].细胞与分子免疫学杂志,2003,19(6)：549-551.
[42]Chung EY, Kim BH, Lee MK, et al. Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase.Planta Med.2003,69(8):710-714.
[43]Moreno JJ.Resveratrol modulates arachidonic acid release,prostaglandin synthesis and fibroblast growth. J Pharmacol Exp Ther.2000;294(1):333-338.
[44]Subbaramaiah, K., W. J. Chung, P. Michaluart, N. Telang, et al.Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells.J. Biol. Chem.1998,273:21875-21882.
[45]Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppressionof7,12-dimethylbenz (a)anthracene-induced mammary carcinogenesis in rats by resveratrol:role of nuclear factor-kappaB, cyclooxy genase 2, and matrix metalloprotease 9.Cancer Res.2002 Sep 1;62 (17):4945-4954.
[46]刘芳,曲极冰,李红等.白藜芦醇抗炎作用机制的初步研究.中国药学杂志,2006,(41)15：1139-1141.
[47]杜金烽,高洁生,陈进伟等.白藜芦醇对大鼠佐剂性关节炎的抗炎作用及对抗胶原Ⅱ抗体的影响.中华风湿病杂志,2009,13(2)：123-126.
[48]Boscolo P, del Signore A, Sabbioni E et al. Effects of resveratrol on lymphocyte proliferation and cytokine release.Ann Clin Lab Sci.2003;33(2):226-231.
[49]Zhong M, Cheng GF, Wang WJ, etal. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice.Phytomedicine.1999;6(2):79-84.
[50]Culpitt SV, Rogers DF, Fenwick PS,et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.Thorax.2003;58(11):942-946.
[51]Kang OH, Jang HJ, Chae HS, et al. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells:pivotal roles of NF-kappaB and MAPK.Pharmacol Res.2009;59(5):330-337.
[52]Onodera S, Tanji H, Suzuki K, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints.Cytokine1999;11:163-167
[53]Molnar V, Garai J. Plant-derived anti-inflammatory compounds affect MIF tautomerase activity. Int Immunopharmacol.2005;5(5):849-856.
[54]Park DW, Baek K, Kim JR, et al. Resveratrol inhibits foam cell formation via NADPH oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1.Exp Mol Med.2009,31; 41(3):171-179.
[55]Zhu J, Yong W, Wu X,et al. Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes.Biochem Biophys Res Commun.2008;369(2):471-477.
[56]Moon SO, Kim W, Sung MJ, et al. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells.Mol Pharmacol.2006;70(1):112-119.
[57]Cullen JP, Morrow D, Jin Y,et al. Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes.Atherosclerosis.2007;195(1): 125-133.
[58]Di Santo A, Mezzetti A, Napoleone E et al. Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells.J Thromb Haemost.2003;1(5):1089-1095.
[59]Ma L, Gao HQ, Li BY, et al., Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators-activated receptory.J Cardiovasc Pharmacol,2007,49(5),293-298.
[60]Hsieh YH,Huang SS, Wei FC,et al.Resveratrol attenuates ischemia-reperfusion-induced leukocyte-endothelial cell adhesive interactions and prolongs allograft survival across the MHC barrier. Circ J 2007; 71:423-428.
[61]Srivastava RK, Unterman TG, Shankar S. FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem.2010;337(1-2):201-212.
[62]李怡棠,沈放,白金叶等.地塞米松、吲哚美辛和白藜芦醇对巴豆油致炎小鼠耳部基质金属酶-9的抑制作用[J].药学学报,2003,28(7)：501
[63]葛恒,张俊峰,郭炳诗等.白藜芦醇抑制巨噬细胞外基质金属蛋白酶诱导物表达.药学学报,2006，41(7)：625-630.
[64]Cao Y, Fu ZD, Wang F, et al.Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants.J Asian Nat Prod Res.2005;7(3):205-213.
[65]Nam NH. Naturally occurring NF-kappaB inhibitors.Mini Rev Med Chem.2006;6(8):945-951.
[66]Leiro J, Arranz JA, Fraiz N, et al. Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling. Int Immunopharmacol.2005;5(2):393-406.
[67]Estrov, Z., S. Shishodia, S. Faderl, D. Harris, Q. Van, H. M.Kantarjian, M. Resveratrol blocks interleukin-1 beta-induced activation of the nuclear transcriptionfactor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003,102(3):987-995.
[68]Holmes-McNary, M., and A. S. Baldwin Jr.2000. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res. 60(13):3477-3483.
[69]Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol.2000,59(7):865-870.
[70]Manna SK, Mukhopadhyay A, Aggarwal BB.Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappaB, activator protein-1 and apoptosis:potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol.2000,164:6509-6519.
[71]Ashikawa K, Majumdar S, Banerjee S,et al.Piceatannol inhibits TNF-Induced NFκB activation and NFκB-mediated gene expression through suppression of IκB kinase and p65 phosphorylation. J Immunol,2002,169:6490-6497.
[72]Pellegatta F, Bertelli AA, Staels B, et al.Different short-and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells.Am J Clin Nutr.2003;77(5):1220-1228
[73]Takada Y, Bhardwaj A, Potdar P, et al.Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin Dl, and abrogation of tumor cell proliferation.Oncogene.2004 9;23(57):9247-9258.
[74]Tong kong AN, Yu R, Hebbar V, et al. Signal transduction events,elicited by cancer prevention compounds.Mutat Res,2001:231-241
[75]Kitasato H, Noda M, Akahoshi T et al. Activated Ras modifies the proliferativeresponse of rheumatoid synovial cells to TNF-alpha and TGF-alpha.Inflamm Res,2001,50 (12):592-597.
[76]Malemud CJ. Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. Curr Opin Pharmacol.2007;7(3):339-343.
[77]Kim AL, Zhu YC, Zhu HJ et al.Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. ExpDermatol,2006,15 (7):538-546.
[78]Alkhalaf M. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. Euro J Cancer Prevention 2007,16:334-341.
[79]Kundu JK, Chun KS, Kim SO, et al. Resveratrol inhibits phorbol ester-induced cyclooxygen ase-2 expression in mouse skin:MAPKs and AP-1 as potential molecular targets. Biofactors. 2004;21(1-4):33-39.
[80]Harris SJ, Foster JG, Ward SG.PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies.Curr Opin Investig Drugs.2009;10(11):1151-1162.
[81]Marone R, Cmiljanovic V, Giese B,et al. Biochim Biophys Acta. Targeting phosphoinositide 3-kinase:moving towards therapy.2008;1784(1):159-185.
[82]Fr6jdo S, Cozzone D, Vidal H,et al. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J.2007,15;406(3):511-518.
[83]Jiang H, Shang X, Wu H,et al.Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol.2009;8(1):25-33.
[84]Roy P, Kalra N, Prasad S,et al.Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res.2009;26(1): 211-217.
[85]Haider UG, Roos TU, Kontaridis MI, et al.Resveratrol inhibits angiotensin Ⅱ-and epidermal growth factor-mediated Akt activation:role of Gab1 and Shp2. Mol Pharmacol.2005;68(1):41-48.
[86]Benitez DA, Pozo-Guisado E, Clementi M, et al.Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer:modulation of the phosphoinositide 3-kinase pathway. Br J Cancer.2007 21;96(10):1595-1604.
[87]Poolman TM, Ng LL, Farmer PB, et al. Inhibition of the respiratory burst by resveratrol in human monocytes:correlation with inhibition of PI3K signaling.Free Radic Biol Med.2005 1; 39 (1):118-132.
[88]Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM.Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer.2004 20;109(2):167-173.
[89]Elmali N, Esenkaya I, Harma A, et al. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res 2005;54(4):158-162
[90]Elmali N, Baysal O, Harma A, et al.Effects of resveratrol in inflammatory arthritis.Inflammation 2007;30(1):1-6.
[91]Shakibaei M, John T, Seifarth C,etal.Resveratrol inhibits IL-1 beta induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann N Y Acad Sci. 2007,1095:554-563.
[92]Csaki C, Keshishzadeh N, Fischer K, et al.Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol,2008,75(3):677-687.
[93]Dave M, Attur M, Palmer G, Al-Mussawir HE, Kennish L, Patel J, et al. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum 2008; 58:2786-2797
[94]Takayama K, Ishida K, Matsushita T, et al. SIRT1 regulation of apoptosis of human chondro cytes.Arthritis Rheum.2009;60(9):2731-2740.
[95]Li X, Phillips FM, An HS,et al. The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc.Spine 2008,15;33(24):2586-2595.
[96]Shakibaei M, Csaki C, Nebrich S, et al. Resveratrol suppresses inflammatory signaling and apoptosis in human articular chondrocytes:potential for use as a novel nutraceutical for the treatment of osteoarthritis.Biochem Pharmacol.2008;76(11):1426-1439.
[97]王静,高洁生,陈进伟等.白藜芦醇对实验性兔骨关节炎软骨细胞凋亡及bcl-2、bax表达的影响.中华风湿病杂志,2009,13(5)：305-308.
[98]刘兆平,于波,李文仙等.白藜芦醇的雌激素样作用研究[J].卫生研究2002,31(3)：188-190.
[99]Basly JP,Fournier FM,LeBail JC,etal.Estrogenic/antiestrogenic and scavenging properties of (E)-and (Z)-resveratrol [J].LifeSci,2000,66 (9):769-777.
[100]张学景,邹永.白藜芦醇的雌激素样作用及相关治疗意义.中国新药杂志,2004,13(8)：692-695.
[101]Mizutani K,Ikeda K,Kawai Y,et al.Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-Elcells [J].BiochemBiophysResCommun,1998,253 (3):859-863.
[102]李文仙,刘兆平,于波等.白藜芦醇对卵巢切除大鼠骨丢失的抑制作用。卫生研究,2003,32(4)：415-416.
[103]El-MowafyAM, WhiteRE. Resveratrol inhibits MAPK activity and nuclear translocation in coronary smooth muscle:reversal of endothelin-1 stimulatory effects.FEBS Lett,1999,451(1) :63-67.
[104]郝捍东,何立人.白藜芦醇抗心血管疾病作用的研究进展[J]。国外医学·心血管疾病分册2003,30(5)：300-302.
[105]白杨,潘隽丽,苏薇薇.白藜芦醇与白藜芦醇苷的研究进展[J].中药材2004,27(1)：55-59.
[106]Csiszar A, Labinskyy N, Olson S, et al.Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension.2009;54(3):668-675.
[107]Yang DL, Zhang HG, Xu YL, et al.Resveratrol Inhibits Right Ventricular Hypertrophy Induced By Monocrotaline In Rats. Clin Exp Pharmacol Physiol.2010;37(2):150-155.
[108]Udai Singh, Narendra Singh, Balwan Singh,et al. Resveratrol (trans-3,5,4'-trihydroxystilbene) induces SIRT1 and down-regulates NF-κB activation to abrogate DSS-induced colitis.J Pharmacol Exp Ther,2010; 332(3):829-839.
[1]Harris SJ, Foster JG, Ward SG.PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies.Curr Opin Investig Drugs.2009;10(11):1151-62.
[2]Marone R, Cmiljanovic V, Giese B,et al. Targeting phosphoinositide 3-kinase:moving towards therapy. Biochim Biophys Acta.2008;1784(1):159-185.
[3]Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al.Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem,2001,70:535-602
[4]Rommel C, Camps M, Ji H.PI3K delta and PI3K gamma:partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol.2007; 7(3):191-201.
[5]Falasca M, Maffucci T, Role of class Ⅱ phosphoinositide 3-kinase in cell signaling, Biochem Soc Trans.2007,35:211-214.
[6]Maffucci T, Cooke FT, Foster FM, et al..Class Ⅱ phosphoinositide 3-kinase defines a novel signaling pathway in cell migration, J Cell Biol,2005,169:789-799.
[7]Stenphen L,Ellson C,Hawkins P.Role of leukocyte chemotaxis and phagocytosis[J].Curr Opin Cell Biol,2002,14(2):202-213.
[8]苏君梅.Akt与肿瘤的关系及其作用机制的研究进展.杭州师范学院学报(医学版),2008,28(4)：272-274.
[9]Sale EM, Hodgkinsen CP, Jones NP, et al.A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNKIand ATP citrate lyase[J].Biochemistry,2006,45(1):213-223.
[10]Osaki M, Oshimura M, Ito H.PDK/Akt pathway:its functions and alterations in human cancer. Apoptasis,2004,9(6):667-676.
[11]Edwards LA,Thiessen B,Dragnwska WH,et al.Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth Oncogene,2005,24(22):3596-3605.
[12]Song G,Ouyang G, Bac S. The activation of Akt/PKB signaling pathway and cell survival[J]. J Cell Mol Med,2005,9(1):59-71.
[13]Reedquist KA, Ludikhuize J, Tak PP. Phosphoinositide 3-kinase signalling and FoxO transcrip tion factors in rheumatoid arthritis. Biochem Soc Trans.2006;34:727-730.
[14]Zhang HG, Wang Y, Xie JF, Liang X, Liu D, Yang P, et al.Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt.Arthritis Rheum 2001;44(7):1555-1567.
[15]Morel J, Audo R, Hahne M, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem.2005;280(16):15709-15718.
[16]Kim G, Jun JB, Elkon KB.Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibro blasts.Arthritis Rheum.2002;46(6):1504-1511.
[17]Pap T, Franz JK, Hummel KM, et al. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res.2000;2(1):59-64
[18]Niquet J, Wasterlain CGBim, Bad, and Bax:a deadly combination in epileptic seizures[J]. J Clin Invest,2004,113(7):960-962.
[19]Xin M, Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphory lation[J].J Biol Chem,2005,280(11):10781-10789.
[20]Birkenkamp KU, Coffer PJ. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J Immunol 2003; 171(4):1623-1629.
[21]Vandermcere F,EI Yazidi,Belkoura I et al.The antiapoptotic effect of fibroblast growth factor-2 is mediated though nuclear factor-kappaB activation induced via interaction between Akt and IKappaB kinase-beta in breast cancer cells[J]. Oncogene,2005,24(35):5482-5491.
[22]Li Q, Verma IM.NF-kappaB regulation in the immune system, Nat Rev. Immunol.2002(2): 725-734.
[23]Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt)pathway in cell cycle progression, Cell Cycle,2003,2:339-345.
[24]Foijer F, Riele H. Check, double check:the G2 barrier to cancer, Cell Cycle 2006,5:831-836.
[25]Montecucco F, Steffens S, Burger F,et al. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1 alpha) on human neutrophils through defined signalling pathways. Cell Signal.2008;20(3):557-68.
[26]Ferrandi C, Ardissone V, Ferro P, et al. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther.2007,322(3):923-930.
[27]Sasaki, T, Irie-Sasaki, J, Jones, R.G, et al. Function of PI3K7 in thymocyte development, T cell activation, and neutrophil migration. Science 2000,287,1040-1046.
[28]Li Z, Jiang H, Xie W, et al.. Roles of PLC-β2 and-β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science,2000:287,1046-1049.
[29]Hirsch E, Katanaev VL, Garlanda C,et al. Central role for G protein-coupled phosphoinositide 3-kinase in inflammation. Science 2000,287,1049-1053.
[30]Camps M, Ruckle T, Ji H, et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med.2005,11,936-943.
[31]Randis TM, Puri KD, Zhou H,et al. Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils. Eur J Immunol.2008,38,1215-1224.
[32]Jones GE, Prigmore E, Calvez R, et al. Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1, Exp Cell Res 2003,290:120-131.
[33]Prete AD, Vermi W, Dander E,et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice, EMBO J.2004,23:3505-3515.
[34]Laffargue M, Calvez R, Finan P, et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function, Immunity,2002,16:441-451.
[35]Kim KW, Cho ML, Park MK,et al. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther.2005; 7(1):R139-148.
[36]Choi YA, Lim HK, Kim JR, et al. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem.2004,27; 279(35):36579-36585.
[37]Foey A, Green P, Foxwell B,et al. Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K:implications for rheumatoid arthritis.Arthritis Res.2002; 4(1):64-70.
[38]Wang K, Scheel-Toellner D,et al. Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways. J Immunol.2003;15;171(2):1035-1041.
[39]Wenink MH, Santegoets KC, Roelofs MF, et al.The inhibitory Fc gamma Ⅱb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.J Immunol.2009, 1;183(7):4509-4520.
[40]Chiu YC, Lin CY, Chen CP,et al. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway.J Immunol. 2009 Aug 15;183(4):2785-2792.
[41]Westra J, Brouwer E, Bos R, et al.Regulation of cytokine-induced HIF-lalpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci.2007;1108:340-348.
[42]Yoo JK, Kwon H, Khil LY, et al.IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways.J Immunol. 2005,175(12):8280-8286.
[43]Forough R,WeylieB,Collins C, et al. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo:role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.J Vase Res.2006; 43(4):327-337.
[44]王聪华,陈丽娜,朱平等.CD147分子通过VEGF促进类风湿关节炎滑膜组织中的血管新生.细胞与分子免疫学杂志,2007,23(5)：426-428.
[45]Tan SY, Xiao L, Pi X,et al. Aberrant Gi protein coupled receptor-mediated cell survival signaling in rheumatoid arthritis B cell lines.Front Biosci.2007, 1;12:1651-1660.
[46]Hofseth LJ. Husaain SP, Wogan GN。 et al. Nitric oxide in cancer and Chemopmvention[J]. Free Radic Biol Med,2003,34(8):955-968.
[47]Ruhul Amin AR, Senga T, et al.Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta:a role for the dual signalling pathways, Akt and Erk Genes Cells.2003;8 (6):515-523.
[48]Park CM,Park MJ.Kwak HJ, etal. Ionizing radiation enbancemmtfix metalloproteinase-2 secretion and invasion of glioma cells through src/epidennal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways[J].Cancer Res,2006,66(17): 8511-8519.
[49]Hayer S, Pundt N, Peters MA, etal.PI3K(?)regulates cartilage damage in chronic inflammatory arthritis,The FASEB Journal.2009;23:4288-4298.
[50]Wu T, Mohan C. The AKT axis as a therapeutic target in autoimmune diseases.Endocr Metab Immune Disord Drug Targets.2009;9(2):145-150.
[51]Miyashita T,Kawakami A,Tamai M, et al. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoprosis inducing ligand mediated apoptosis in rheumatoid synovial cells. Biochem Biophys Res Commun,2003,312 (2):397-404.
[52]Dhaouadi T, Sfar I, Abelmoula L,et al.Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review.Tunis Med. 2007;85(12):991-998.
[53]Wang CR, Shiau AL, Chen SY, et al. Amelioration of collagen-induced arthritis in rats by adenovirus-mediated PTEN gene transfer.Arthritis Rheum.2008;58(6):1650-1656.
[54]Ameriks MK, Venable JD. Small molecule inhibitors of phosphoinositide 3-kinase (PI3K) delta and gamma.Curr Top Med Chem.2009;9(8):738-753.
[55]Stein RC, Waterfield MD. PI3-kinase inhibition:a target for drug development? Mol Med Today 2000; 6(9):347-357.
[56]Sadhu C, Dick K, Tino WT, Staunton DE. Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun 2003; 308(4):764-769.
[57]Sadhu C, Masinovsky B, Dick K, Sowell CG, Staunton DE.Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 2003; 170(5):2647-2654.
[58]Sawyer C, Sturge J, Bennett DC, O'Hare MJ, Allen WE, Bain J, etal. Regulation of breast cancer cell chemotaxis by thephosphoinositide 3-kinase p110delta. Cancer Res 2003; 63(7):1667-1675.
[59]Reedquist KA,LudikhuizeJ,Tak PP.Phosphoinositide3-kinase signalling and FoxO transcription factors in rheumatoid arthritis. Biochem Soc Trans.2006; 34(5):727-730.
[2]奚正德,李宁丽,张雁云等.滑膜成纤维细胞在关节炎发病中的作用.自然杂志,2004；26(4)：205-208.
[3]Harris SJ, Foster JG, Ward SG. PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies.Curr Opin Investig Drugs.2009;10(11):1151-1162.
[4]Marone R, Cmiljanovic V, Giese B,et al. Targeting phosphoinositide 3-kinase:moving towards therapy. Biochim Biophys Acta.2008;1784(1):159-185.
[5]苏君梅.Akt与肿瘤的关系及其作用机制的研究进展.杭州师范学院学报(医学版),2008；2(4)：272-274.
[6]Reedquist KA, Ludikhuize J, Tak PP. Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis.Biochem Soc Trans.2006;34:727-730.
[7]Montecucco F, Steffens S, Burger F,et al. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD 18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-lalpha) on human neutrophils through defined signalling pathways. Cell Signal. 2008;20(3):557-568.
[8]Ferrandi C, Ardissone V, Ferro P, et al. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther.2007;322(3):923-930.
[9]Kim KW, Cho ML, Park MK,et al.Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther.2005;7(1):R139-148.
[10]Choi YA, Lim HK, Kim JR, et al. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem.2004;27;279(35):36579-36585.
[11]Wenink MH, Santegoets KC, Roelofs MF, et al.The inhibitory Fc gamma Ⅱb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.J Immunol.2009, 1;183(7):4509-4520.
[12]Chiu YC, Lin CY, Chen CP,et al. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway.J Immunol. 2009;15,183(4):2785-2792.
[13]Westra J, Brouwer E, Bos R, et al.Regulation of cytokine-induced HIF-lalpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci.2007;1108:340-348.
[14]Forough R,WeylieB,Collins C, et al. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo:role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.J Vasc Res.2006; 43(4):327-337.
[15]Park CM,Park MJ, Kwak HJ,etal.Ionizing radiation enbancemmtfix metalloproteinase-2 secretion and invasion of glioma cells through src/epidennal growth factor receptor-mediated p38 /Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res,2006,66(17): 8511-8519.
[16]Hayer S, Pundt N, Peters MA, etal.PI3Kγ regulates cartilage damage in chronic inflammatory arthritis, The FASEB Journal.2009;23:4288-4298.
[17]]Wu T, Mohan C. The AKT axis as a therapeutic target in autoimmune diseases.Endocr Metab Immune Disord Drug Targets.2009;9(2):145-150.
[18]Harikumar KB, Aggarwal BB. Resveratrol:a multitargeted agent for age-associated chronic diseases.Cell Cycle.2008,15;7(8):1020-1035.
[19]朱青,韩苏夏,马瑾璐.白藜芦醇抗肿瘤活性研究进展.,现代肿瘤医学,2006,14(5)：634-636.
[20]Fr6jdo S, Cozzone D, Vidal H,et al. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J.2007; 15;406(3):511-518.
[21]Khanna D, Sethi G, Ahn KS, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol.2007;7(3):344-351.
[22]Tang LL, Gao JS, Chen XR, et al. Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheumatoid arthritis and its mechanism in vitro.Zhong Nan Da Xue Xue Bao Yi Xue Ban.2006;31(4):528-533.
[23]唐玲丽,高洁生,陈新瑞.白藜芦醇体外诱导类风湿关节炎滑膜细胞凋亡的实验研究.中南药学,2006,(4)4：245-248.
[24]唐玲丽,余平,田静等。类风湿关节炎滑膜细胞凋亡过程中白藜芦醇的诱导作用及天冬氨酸特异性半胱氨酸蛋白酶3的活化.中国临床康复,2005,9(23)：142-144.
[25]Byun HS, Song JK, Kim YR.et al. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes Rheumatol 2008;47:301-308.
[26]杜金烽,高洁生,陈进伟等.白藜芦醇对大鼠佐剂性关节炎的抗炎作用及对抗胶原Ⅱ抗体的影响。中华风湿病杂志,2009,13(2)：123-126.
[1]Garcia S, Bodano A, Pablos JL, et al. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts. Ann Rheum Dis ,2008;67:631-637
[2]Yoo SA, Park BH, Park GS, et al. Calcineurin Is Expressed and Plays a Critical Role in Inflammatory Arthritis.J Immunol,2006; 177:2681-2690.
[3]黄世峰,肖长虹,顾为望等.人类风湿性关节炎B型滑膜细胞的分离、培养和纯化.广东医学,2007,28(2)：197-199.
[4]蒋建平,朱志刚,易朝辉等.人关节滑膜A型和B型细胞的纯化分离和体外培养.解放军医学杂志2001,26(5)：387-388.
[5]刘晓燕,谢华福,宋杰等.人滑膜细胞体外培养的比较研究.泸州医学院学报,2005,(6)：510-512.
[6]彭卫华,侯凡凡,蒋建平等.改良的胶原酶滑膜细胞分离培养法.第一军医大学学报,2000,20(5)：469-470.
[7]舒强,李兴福,刘花香等.类风湿关节炎滑膜成纤维样细胞增殖特性的体外研究.山东大学学报(医学版),2006,11(44)：1095-1099.
[8]Lehmann J, JungelA, Lehmann I, et al. Grafting of fibroblasts isolated from the synovial membrane of rheumatoid arthritis (RA) patients induces chronic arthritis in SCID mice-A novel model for studying the arthritogenic role of RA fibroblasts in vivo. J Autoimmun,2000,15 (3):301-313.
[9]史战国,朱平,卢宁等.类风湿关节炎成纤维样滑膜细胞的表型及其侵蚀软骨的特性.细胞与分子免疫学杂志,2006,22(4)：493-495.
[10]Harikumar KB, Aggarwal BB. Resveratrol:a multitargeted agent for age-associated chronic diseases. Cell Cycle,2008,15;7(8):1020-1035.
[11]朱青,韩苏夏,马瑾璐.白藜芦醇抗肿瘤活性研究进展.现代肿瘤医学,2006,14(5)：634-636.
[12]Clement MV, Hirpara JL, Chawdhury SH, etal.Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells.Blood,1998,92 (3):996-1002.
[13]KuoPL,ChiangLC,LinCC. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in HepG2 cells. Life Sci,2002,72 (1):23-24.
[14]ShihA,DavisFB,LinHY,et al. Resveratrol induces apoptosis in thyroid cancer cell lines via MAPK-and-p53-dependent mechanism.Clin Endocrinol Metab,2002,87 (3):1223-1232.
[15]AttenMJ,AttarBM,MilsonT,et al. Resveratrol-induced inactivation of human gastricaden ocarcinoma cells through a proteinkinaseC-mediated mechanism. Biochem Pharmacol,2001,62 (10):1423-1432.
[16]RomanV,BillardC; KernC,et al. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukemia. BrJ Haematol,2002,117 (4):842-851.
[17]Latruffe N, Nelmas D, Jannin B, et al. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent. Int J Mol Med,2002; 10 (6):755-760.
[18]于良,孙中杰,吴胜利等.白藜芦醇对小鼠移植性肝癌组织中细胞周期蛋白的影响.第四军医大学学报,2002；23(23)：2172-2174.
[19]朱青,张王刚,王立锋等.白藜芦醇诱导肿瘤细胞凋亡和细胞周期阻滞的作用及机制。第四军医大学学报,2005；26(21)1935-1937.
[20]Adhami VM, Afaq F, Ahmad N. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.Biochem Biophys Res Commun,2001,288(3):579-585.
[21]Atten MJ, Godoy-RomeroE,Attar BM, et al. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells[J].Invest New Drugs,2005,23(2):111-119.
[22]Castello L, Tessitore L. Resveratrol inhibits cell cycle progression in U937cells [J].Oncol Rep,2005,13(1):133-137.
[23]Chen Y, Tseng SH, Lai HS, et al. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice[J].Surgery.2004,16(1):57-66.
[24]田雪梅,张展霞.白藜芦醇促进Ca2+介导的线粒体通透转变孔道开放.药学学报,2003,38(2)：81-84.
[25]Mouria M,Gukovskays AS, Juang Y,et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome crelease and apoptosis.Int J Cancer,2002,98(5):761-769.
[26]ZiGang Dong.Molecular mechanism of the chemopreventive effect of resveratorl. Mutation Research,2003,(523-524):145-150.
[27]冯骥良,温巧莲,何伟玲等。白藜芦醇以caspase依赖和非依赖两种方式导致Jurkat细胞死亡细胞生物学杂志,2007,29：103-108.
[28]唐旭东,周克元,陈小文等.白藜芦醇诱导鼻咽癌细胞CNE-2Z凋亡过程中caspase-6的活化。中国免疫学杂志,2003(19)2：100-103.
[29]唐旭东,周克元,丁航.白藜芦醇诱导CNE-2Z细胞凋亡过程中caspase-3的活化.免疫学杂志,2003(19)1：23-29.
[30]郝春燕,苏海翔,魏虎来等.白藜芦醇通过Fas依赖途径诱导K562细胞凋亡.实用癌症杂志,2004,19(6)：561-563.
[31]Nakagawa H, Kiyozuka Y, Uemura YJ,et al. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. Cancer Res Clin Oncol.2001;127(4):258-264.
[32]孙春艳,胡豫,刘新月等.白藜芦醇对多发性骨髓瘤细胞的体外抗癌作用.中草药,2007,38(1)：80-84.
[33]林江,藏宁,陶红等.bcl-2和bax及NF-kB在白藜芦醇诱导肝癌细胞凋亡中的作用.中国微生态学杂志,2005；17(3)：164-165.
[34]Tang LL, Gao JS, Chen XR, et al. Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheumatoid arthritis and its mechanism in vitro.Zhong Nan Da Xue Xue Bao Yi Xue Ban.2006;31(4):528-533.
[35]唐玲丽,高洁生,陈新瑞.白藜芦醇体外诱导类风湿关节炎滑膜细胞凋亡的实验研究。中南药学,2006,(4)4：245-248.
[36]唐玲丽,余平,田静等.类风湿关节炎滑膜细胞凋亡过程中白藜芦醇的诱导作用及天冬氨酸特异性半胱氨酸蛋白酶3的活化.中国临床康复,2005,9(23)：142-144.
[37]Byun HS, Song JK, Kim YR.et al. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes Rheumatol,2008;47:301-308.
[38]Niquet J, Wasterlain CG. Bim, Bad,and Bax:a deadly combination in epileptic seizures[J]. J Clin Invest,2004,113(7):960-962.
[39]Pettipher ER,Higgs GA,Henderson B.Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.Proc Natl Acad Sci USA,1986,83:8749-8753.
[40]Sun HB, Nalim R, Yokota H1 Exp ression and axtivities of matrix metallop roteinases under oscillatory shear in IL-1 stimulated synovial cuesl Connect Tissue Res,2003,44(1):42-49.
[41]Ribbens C, Andre B, Kaye O, et al. Synovial fluid matrixmetallop roteinase-3 levels are increased in inflammatory arthritiswhether erosive or not. J Rheumatol,2000,39 (12):1357-1365.
[42]Kane D, Jensen L, Grehan S, et al.Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage pannus junctionl J Rheumatol,2004,31 (7):1274-1280.
[43]Kamphuis S, Hrafnkelsdottir K, Klein MR, et al. Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.Arthritis Res Ther,2006,8 (6):R178.
[44]Canu V, Goldberg R, Peppard J, et al. Inhibition of interleukin-1αinduced cartilage by matrix protein degradation in bovine articular by matrix metalloproteinases in the generation of cartilage oligomeirix protein fragments in arthritic synovial fluid[J]. Arthritis Rheum,1998,41 (12):2143-2151.
[45]Boscolo P, del Signore A, Sabbioni E et al. Effects of resveratrol on lymphocyte proliferation and cytokine release.Ann Clin Lab Sci.2003;33(2):226-231.
[46]Zhong M, Cheng GF, Wang WJ, etal. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice.Phytomedicine.1999;6(2):79-84.
[47]Culpitt SV, Rogers DF, Fenwick PS,et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.Thorax.2003;58(11):942-946.
[48]Kang OH, Jang HJ, Chae HS, et al. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells:pivotal roles of NF-kappaB and MAPK.Pharmacol Res.2009;59(5):330-337.
[49]Shakibaei M, Csaki C, Nebrich S, et al. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes:potential for use as a novel nutraceutical for the treatment of osteoarthritis.Biochem Pharmacol.2008;76(11):1426-1439.
[50]Banerjee S, Bueso Ramas C, Aggarwal BB. Suppression of 7,12 dimethybenz(a) anthracene-induced mammary carcinogenesis in rats by resveratrol:rule of nuclear factor-kappB, cyclooxygenase 2, and matrix metalloprotrase 9 [J]. Cancer Res,2002,62 (17):4945-4954
[51]李怡棠,沈放,白金叶等.地塞米松、吲哚美辛和白藜芦醇对巴豆油致炎小鼠耳部基质金属酶-9的抑制作用[J].药学学报,2003,28(7)：501
[52]葛恒,张俊峰,郭炳诗等.白藜芦醇抑制巨噬细胞外基质金属蛋白酶诱导物表达。药学学报,2006,41(7)：625-630.
[53]Cao Y, Fu ZD, Wang F, et al.Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants.J Asian Nat Prod Res.2005;7(3):205-213
[54]Harris SJ, Foster JG, Ward SG.PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies.Curr Opin Investig Drugs.2009;10(11):1151-1162.
[55]Marone R, Cmiljanovic V, Giese B,et al. Biochim Biophys Acta. Targeting phosphoinositide 3-kinase:moving towards therapy.2008;1784(1):159-185.
[56]苏君梅.Akt与肿瘤的关系及其作用机制的研究进展.杭州师范学院学报(医学版),2008,28(4)：272-274.
[57]Reedquist KA, Ludikhuize J, Tak PP. Phosphoinositide 3-kinase signalling and FoxO transcrip-tion factors in rheumatoid arthritis.Biochem Soc Trans.2006;34:727-730.
[58]Montecucco F, Steffens S, Burger F,et al. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CDllb/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1 alpha) on human neutrophils through defined signalling pathways. Cell Signal. 2008;20(3):557-568.
[59]Ferrandi C, Ardissone V, Ferro P, et al. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther.2007,322(3):923-930.
[60]Wenink MH, Santegoets KC, Roelofs MF, et al.The inhibitory Fc gamma Ⅱb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.J Immunol,.2009, 1;183(7):4509-4520.
[61]Chiu YC, Lin CY, Chen CP,et al. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway.J Immunol. 2009;183(4):2785-2792.
[62]Westra J, Brouwer E, Bos R, et al.Regulation of cytokine-induced HIF-lalpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci.2007;1108:340-348.
[63]Hayer S, Pundt N, Peters MA, etal.PI3Kγregulates cartilage damage in chronic inflammatory arthritis,The FASEB Journal.2009;23:4288-4298.
[64]]Wu T, Mohan C. The AKT axis as a therapeutic target in autoimmune diseases.Endocr Metab Immune Disord Drug Targets.2009;9(2):145-150.
[65]Frojd6 S, Cozzone D, Vidal H,et al. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J.2007,15;406(3):511-518.
[66]Xu H,He Y,Yang X, et al.Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.Rheumatology,2007;46 (6):920-926.
[67]Kim HR, Cho ML, Kim KW, et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways.Rheumatology,2007;46 (1):57-64.
[68]Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al.Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem,2001,70:535-602
[69]Rommel C, Camps M, Ji H.PI3K delta and PI3K gamma:partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol.2007; 7(3):191-201.
[70]Sale EM, Hodgkinsen CP, Jones NP, et al.A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNKIand ATP citratelyase[J].Biochemistry,2006,45(I):213-223.
[71]Zhang HG, Wang Y, Xie JF, et al.Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum 2001;44(7):1555-1567.
[72]Morel J, Audo R, Hahne M, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem.2005;280(16):15709-15718.
[73]Kim G, Jun JB, Elkon KB.Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts.Arthritis Rheum.2002;46(6):1504-1511.
[74]Sasaki T, Irie-Sasaki J, Jones RG, et al. Function of PI3K7 in thymocyte development, T cell activation, and neutrophil migration. Science 2000,287,1040-1046.
[75]Li Z, Jiang H, Xie W, et al.. Roles of PLC-β2 and-β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science,2000:287,1046-1049
[76]Hirsch E, Katanaev VL, Garlanda C,et al. Central role for G protein-coupled phosphoinositide 3-kinase in inflammation. Science 2000,287,1049-1053
[77]Camps M, Ruckle T, Ji H, et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med.2005,11,936-943.
[78]Randis TM, Puri KD, Zhou H,et al. Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils. Eur J Immunol.2008,38,1215-1224.
[79]Yoo JK, Kwon H, Khil LY, et al.IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways.J Immunol. 2005,175(12):8280-8286.
[80]Forough R,WeylieB,Collins C, et al. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo:role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.J Vasc Res.2006; 43(4):327-337.
[81]Wang K, Scheel-Toellner D,et al. Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways.J Immunol.2003;171(2):1035-1041.
[82]王聪华,陈丽娜,朱平等。CD147分子通过VEGF促进类风湿关节炎滑膜组织中的血管新生。细胞与分子免疫学杂志。2007,23(5)：426-428.
[83]Miyashita T,Kawakami A,Tamai M, et al. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoprosis inducing ligand mediated apoptosis in rheumatoid synovial cells. Biochem Biophys Res Commun,2003,312 (2):397-404.
[84]Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM.Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer.2004 20;109(2):167-173.
[1]Harikumar KB, Aggarwal BB. Resveratrol:a multitargeted agent for age-associated chronic diseases.Cell Cycle.2008,15;7(8):1020-1035.
[2]朱青,韩苏夏,马瑾璐.白藜芦醇抗肿瘤活性研究进展.现代肿瘤医学,2006,14(5)：634-636。
[3]Khanna D, Sethi G, Ahn KS, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol.2007;7(3):344-351.
[4]傅喆暾,张蓉,黄宝康等天然植物中活性成分白藜芦醇的作用研究进展.现代中药研究与实践.2005,19(2)：62-64。
[5]Bertelli A,Bertelli AA, Gozzini A,et al. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res.1998.24:133-138.
[6]Fremont, L. Biological effects of resveratrol. Life Sci.2000,66(8):663-673.
[7]赵克森.白藜芦醇的一般生物学作用,国外医学卫生学分册,2002, (6)：374-376.
[8]Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratr-ol to rats for 28days is not harmful[J].J Nutr,2002,132(2):257-260.
[9]钟芳,罗少军,汤少明.白藜芦醇抑制细胞增殖研究新进展.中草药,2003,34,(5)附2-4.
[10]付丽华,胡玉红，孙盛等.白藜芦醇抗肿瘤作用的研究进展.黑龙江医药科学,2006,29(6)：98-100.
[11]Fontecave M, Lepoivre M, Elleingand E,et al. Resveratrol, a remarkable inhibitor of ribonucle-otide reductase. FEBS Lett.1998,16;421(3):277-279.
[12]Sun NJ, Woo SH, Cassady JM, Snapka RM.DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia.J Nat Prod.1998;61(3):362-366.
[13]Latruffe N, Nelmas D, Jannin B, et al. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent [J].Int J Mol Med,2002;10 (6):755-760.
[14]于良,孙中杰,吴胜利等.白藜芦醇对小鼠移植性肝癌组织中细胞周期蛋白的影响[J].第四军医大学学报,2002；23(23)：2172-2174.
[15]朱青,张王刚,王立锋等.白藜芦醇诱导肿瘤细胞凋亡和细胞周期阻滞的作用及机制.第四军医大学学报,2005；26(21)：1935-1937.
[16]Adhami VM, Afaq F, Ahmad N Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.Biochem Biophys Res Commun,2001,288(3):579-585
[17]Atten MJ, Godoy-RomeroE,Attar BM, et al. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells[J].Invest New Drugs,2005,23(2):111-119.
[18]Castello L, Tessitore L. Resveratrol inhibits cell cycle progression in U937cells [J].Oncol Rep,2005,13(1):133-137.
[19]Chen Y, Tseng SH, Lai HS, et al. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice[J].Surgery.2004,16(1):57-66.
[20]Fuggetta MP, Lanzilli G, Tricarico M, et al.Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.J Exp Clin Cancer Res.2006;25(2):189-193.
[21]Lanzilli G, Fuggetta MP, Tricarico M, et al.Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol.2006;28(3):641-648.
[22]田雪梅,张展霞.白藜芦醇促进Ca2+介导的线粒体通透转变孔道开放.药学学报,(2)：81-84。
[23]Mouria M,Gukovskays AS, Juang Y,et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochromecrelease and apoptosis[J].Int J Cancer,2002,98(5):761-769.
[24]Nakagawa H, Kiyozuka Y, Uemura YJ,et al. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. Cancer Res Clin Oncol.2001;127(4):258-264.
[25]孙春艳,胡豫,刘新月等.白藜芦醇对多发性骨髓瘤细胞的体外抗癌作用.中草药,2007,38(1)：80-84.
[26]林江,藏宁,陶红等.bcl-2和bax及NF-kB在白藜芦醇诱导肝癌细胞凋亡中的作用.中国微生态学杂志.2005,17(3)：164-165.
[27]唐旭东,周克元,陈小文等.白藜芦醇诱导鼻咽癌细胞CNE-2Z凋亡过程中caspase-6的活化。中国免疫学杂志,2003：(19)2：100-103.
[28]唐旭东,周克元,丁航.白藜芦醇诱导CNE-2Z细胞凋亡过程中caspase-3的活化.免疫学杂志，2003；(19)1：23-29.
[29]ZiGang Dong.Molecular mechanism of the chemopreventive effect of resveratorl[J]. Mutation Research,2003, (523-524):145-150.
[30]胜利,安利峰,何烨等.白藜芦醇抑制胆囊癌细胞生长与诱导细胞凋亡的实验研究.中药材 2005,28(6)：489-491
[31]冯骥良,温巧莲,何伟玲等.白藜芦醇以caspase依赖和非依赖两种方式导致Jurkat细胞死亡.细胞生物学杂志,2007,29：103-108.
[32]Clement MV, Hirpara JL, Chawdhury SH, etal.Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells.Blood,1998;92 (3):996-1002.
[33]郝春燕,苏海翔,魏虎来等.白藜芦醇通过Fas依赖途径诱导K562细胞凋亡。实用癌症杂志,2004,19(6)：561-563.
[34]Tang LL, Gao JS, Chen XR, et al. Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheumatoid arthritis and its mechanism in vitro.Zhong Nan Da Xue Xue Bao Yi Xue Ban.2006;31(4):528-533.
[35]唐玲丽,高洁生,陈新瑞.白藜芦醇体外诱导类风湿关节炎滑膜细胞凋亡的实验研究.中南药学,2006,(4)4：245-248.
[36]唐玲丽,余平,田静等.类风湿关节炎滑膜细胞凋亡过程中白藜芦醇的诱导作用及天冬氨酸特异性半胱氨酸蛋白酶3的活化.中国临床康复,2005,9(23)：142-144.
[37]Byun HS, Song JK, Kim YR.et al. Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. Rheumatol,2008;47:301-308.
[38]Falchetti R, Fuggeta MP, Lanzili G,et al.Effects of resveratrol on human immune cell function[J].Life Science,2001,70:81-96.
[39]Xiao HuaGao,Dorrah Deeb, Joseph M edia,et a l.Immunodulatory activity of resveratol: discrepant in vitro and in vivo immunological effects[J].Biochem Pharmacol,2003,66:2427-2435.
[40]高路,袁育康,吕卓人等.白藜芦醇的免疫调节作用.西安交通大学学报(医学版),2003,24(2)：121-123.
[41]于良,吴胜利,张梅等.白藜芦醇及与环抱菌素A联用对人外周血T细胞免疫功能的影响[J].细胞与分子免疫学杂志,2003,19(6)：549-551.
[42]Chung EY, Kim BH, Lee MK, et al. Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase.Planta Med.2003,69(8):710-714.
[43]Moreno JJ.Resveratrol modulates arachidonic acid release,prostaglandin synthesis and fibroblast growth. J Pharmacol Exp Ther.2000;294(1):333-338.
[44]Subbaramaiah, K., W. J. Chung, P. Michaluart, N. Telang, et al.Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells.J. Biol. Chem.1998,273:21875-21882.
[45]Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppressionof7,12-dimethylbenz (a)anthracene-induced mammary carcinogenesis in rats by resveratrol:role of nuclear factor-kappaB, cyclooxy genase 2, and matrix metalloprotease 9.Cancer Res.2002 Sep 1;62 (17):4945-4954.
[46]刘芳,曲极冰,李红等.白藜芦醇抗炎作用机制的初步研究.中国药学杂志,2006,(41)15：1139-1141.
[47]杜金烽,高洁生,陈进伟等.白藜芦醇对大鼠佐剂性关节炎的抗炎作用及对抗胶原Ⅱ抗体的影响.中华风湿病杂志,2009,13(2)：123-126.
[48]Boscolo P, del Signore A, Sabbioni E et al. Effects of resveratrol on lymphocyte proliferation and cytokine release.Ann Clin Lab Sci.2003;33(2):226-231.
[49]Zhong M, Cheng GF, Wang WJ, etal. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice.Phytomedicine.1999;6(2):79-84.
[50]Culpitt SV, Rogers DF, Fenwick PS,et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.Thorax.2003;58(11):942-946.
[51]Kang OH, Jang HJ, Chae HS, et al. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells:pivotal roles of NF-kappaB and MAPK.Pharmacol Res.2009;59(5):330-337.
[52]Onodera S, Tanji H, Suzuki K, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints.Cytokine1999;11:163-167
[53]Molnar V, Garai J. Plant-derived anti-inflammatory compounds affect MIF tautomerase activity. Int Immunopharmacol.2005;5(5):849-856.
[54]Park DW, Baek K, Kim JR, et al. Resveratrol inhibits foam cell formation via NADPH oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1.Exp Mol Med.2009,31; 41(3):171-179.
[55]Zhu J, Yong W, Wu X,et al. Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes.Biochem Biophys Res Commun.2008;369(2):471-477.
[56]Moon SO, Kim W, Sung MJ, et al. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells.Mol Pharmacol.2006;70(1):112-119.
[57]Cullen JP, Morrow D, Jin Y,et al. Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes.Atherosclerosis.2007;195(1): 125-133.
[58]Di Santo A, Mezzetti A, Napoleone E et al. Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells.J Thromb Haemost.2003;1(5):1089-1095.
[59]Ma L, Gao HQ, Li BY, et al., Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators-activated receptory.J Cardiovasc Pharmacol,2007,49(5),293-298.
[60]Hsieh YH,Huang SS, Wei FC,et al.Resveratrol attenuates ischemia-reperfusion-induced leukocyte-endothelial cell adhesive interactions and prolongs allograft survival across the MHC barrier. Circ J 2007; 71:423-428.
[61]Srivastava RK, Unterman TG, Shankar S. FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem.2010;337(1-2):201-212.
[62]李怡棠,沈放,白金叶等.地塞米松、吲哚美辛和白藜芦醇对巴豆油致炎小鼠耳部基质金属酶-9的抑制作用[J].药学学报,2003,28(7)：501
[63]葛恒,张俊峰,郭炳诗等.白藜芦醇抑制巨噬细胞外基质金属蛋白酶诱导物表达.药学学报,2006，41(7)：625-630.
[64]Cao Y, Fu ZD, Wang F, et al.Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants.J Asian Nat Prod Res.2005;7(3):205-213.
[65]Nam NH. Naturally occurring NF-kappaB inhibitors.Mini Rev Med Chem.2006;6(8):945-951.
[66]Leiro J, Arranz JA, Fraiz N, et al. Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling. Int Immunopharmacol.2005;5(2):393-406.
[67]Estrov, Z., S. Shishodia, S. Faderl, D. Harris, Q. Van, H. M.Kantarjian, M. Resveratrol blocks interleukin-1 beta-induced activation of the nuclear transcriptionfactor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003,102(3):987-995.
[68]Holmes-McNary, M., and A. S. Baldwin Jr.2000. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res. 60(13):3477-3483.
[69]Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol.2000,59(7):865-870.
[70]Manna SK, Mukhopadhyay A, Aggarwal BB.Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappaB, activator protein-1 and apoptosis:potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol.2000,164:6509-6519.
[71]Ashikawa K, Majumdar S, Banerjee S,et al.Piceatannol inhibits TNF-Induced NFκB activation and NFκB-mediated gene expression through suppression of IκB kinase and p65 phosphorylation. J Immunol,2002,169:6490-6497.
[72]Pellegatta F, Bertelli AA, Staels B, et al.Different short-and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells.Am J Clin Nutr.2003;77(5):1220-1228
[73]Takada Y, Bhardwaj A, Potdar P, et al.Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin Dl, and abrogation of tumor cell proliferation.Oncogene.2004 9;23(57):9247-9258.
[74]Tong kong AN, Yu R, Hebbar V, et al. Signal transduction events,elicited by cancer prevention compounds.Mutat Res,2001:231-241
[75]Kitasato H, Noda M, Akahoshi T et al. Activated Ras modifies the proliferativeresponse of rheumatoid synovial cells to TNF-alpha and TGF-alpha.Inflamm Res,2001,50 (12):592-597.
[76]Malemud CJ. Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. Curr Opin Pharmacol.2007;7(3):339-343.
[77]Kim AL, Zhu YC, Zhu HJ et al.Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. ExpDermatol,2006,15 (7):538-546.
[78]Alkhalaf M. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. Euro J Cancer Prevention 2007,16:334-341.
[79]Kundu JK, Chun KS, Kim SO, et al. Resveratrol inhibits phorbol ester-induced cyclooxygen ase-2 expression in mouse skin:MAPKs and AP-1 as potential molecular targets. Biofactors. 2004;21(1-4):33-39.
[80]Harris SJ, Foster JG, Ward SG.PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies.Curr Opin Investig Drugs.2009;10(11):1151-1162.
[81]Marone R, Cmiljanovic V, Giese B,et al. Biochim Biophys Acta. Targeting phosphoinositide 3-kinase:moving towards therapy.2008;1784(1):159-185.
[82]Fr6jdo S, Cozzone D, Vidal H,et al. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J.2007,15;406(3):511-518.
[83]Jiang H, Shang X, Wu H,et al.Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol.2009;8(1):25-33.
[84]Roy P, Kalra N, Prasad S,et al.Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res.2009;26(1): 211-217.
[85]Haider UG, Roos TU, Kontaridis MI, et al.Resveratrol inhibits angiotensin Ⅱ-and epidermal growth factor-mediated Akt activation:role of Gab1 and Shp2. Mol Pharmacol.2005;68(1):41-48.
[86]Benitez DA, Pozo-Guisado E, Clementi M, et al.Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer:modulation of the phosphoinositide 3-kinase pathway. Br J Cancer.2007 21;96(10):1595-1604.
[87]Poolman TM, Ng LL, Farmer PB, et al. Inhibition of the respiratory burst by resveratrol in human monocytes:correlation with inhibition of PI3K signaling.Free Radic Biol Med.2005 1; 39 (1):118-132.
[88]Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM.Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer.2004 20;109(2):167-173.
[89]Elmali N, Esenkaya I, Harma A, et al. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res 2005;54(4):158-162
[90]Elmali N, Baysal O, Harma A, et al.Effects of resveratrol in inflammatory arthritis.Inflammation 2007;30(1):1-6.
[91]Shakibaei M, John T, Seifarth C,etal.Resveratrol inhibits IL-1 beta induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann N Y Acad Sci. 2007,1095:554-563.
[92]Csaki C, Keshishzadeh N, Fischer K, et al.Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol,2008,75(3):677-687.
[93]Dave M, Attur M, Palmer G, Al-Mussawir HE, Kennish L, Patel J, et al. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum 2008; 58:2786-2797
[94]Takayama K, Ishida K, Matsushita T, et al. SIRT1 regulation of apoptosis of human chondro cytes.Arthritis Rheum.2009;60(9):2731-2740.
[95]Li X, Phillips FM, An HS,et al. The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc.Spine 2008,15;33(24):2586-2595.
[96]Shakibaei M, Csaki C, Nebrich S, et al. Resveratrol suppresses inflammatory signaling and apoptosis in human articular chondrocytes:potential for use as a novel nutraceutical for the treatment of osteoarthritis.Biochem Pharmacol.2008;76(11):1426-1439.
[97]王静,高洁生,陈进伟等.白藜芦醇对实验性兔骨关节炎软骨细胞凋亡及bcl-2、bax表达的影响.中华风湿病杂志,2009,13(5)：305-308.
[98]刘兆平,于波,李文仙等.白藜芦醇的雌激素样作用研究[J].卫生研究2002,31(3)：188-190.
[99]Basly JP,Fournier FM,LeBail JC,etal.Estrogenic/antiestrogenic and scavenging properties of (E)-and (Z)-resveratrol [J].LifeSci,2000,66 (9):769-777.
[100]张学景,邹永.白藜芦醇的雌激素样作用及相关治疗意义.中国新药杂志,2004,13(8)：692-695.
[101]Mizutani K,Ikeda K,Kawai Y,et al.Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-Elcells [J].BiochemBiophysResCommun,1998,253 (3):859-863.
[102]李文仙,刘兆平,于波等.白藜芦醇对卵巢切除大鼠骨丢失的抑制作用。卫生研究,2003,32(4)：415-416.
[103]El-MowafyAM, WhiteRE. Resveratrol inhibits MAPK activity and nuclear translocation in coronary smooth muscle:reversal of endothelin-1 stimulatory effects.FEBS Lett,1999,451(1) :63-67.
[104]郝捍东,何立人.白藜芦醇抗心血管疾病作用的研究进展[J]。国外医学·心血管疾病分册2003,30(5)：300-302.
[105]白杨,潘隽丽,苏薇薇.白藜芦醇与白藜芦醇苷的研究进展[J].中药材2004,27(1)：55-59.
[106]Csiszar A, Labinskyy N, Olson S, et al.Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension.2009;54(3):668-675.
[107]Yang DL, Zhang HG, Xu YL, et al.Resveratrol Inhibits Right Ventricular Hypertrophy Induced By Monocrotaline In Rats. Clin Exp Pharmacol Physiol.2010;37(2):150-155.
[108]Udai Singh, Narendra Singh, Balwan Singh,et al. Resveratrol (trans-3,5,4'-trihydroxystilbene) induces SIRT1 and down-regulates NF-κB activation to abrogate DSS-induced colitis.J Pharmacol Exp Ther,2010; 332(3):829-839.
[1]Harris SJ, Foster JG, Ward SG.PI3K isoforms as drug targets in inflammatory diseases:lessons from pharmacological and genetic strategies.Curr Opin Investig Drugs.2009;10(11):1151-62.
[2]Marone R, Cmiljanovic V, Giese B,et al. Targeting phosphoinositide 3-kinase:moving towards therapy. Biochim Biophys Acta.2008;1784(1):159-185.
[3]Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al.Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem,2001,70:535-602
[4]Rommel C, Camps M, Ji H.PI3K delta and PI3K gamma:partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol.2007; 7(3):191-201.
[5]Falasca M, Maffucci T, Role of class Ⅱ phosphoinositide 3-kinase in cell signaling, Biochem Soc Trans.2007,35:211-214.
[6]Maffucci T, Cooke FT, Foster FM, et al..Class Ⅱ phosphoinositide 3-kinase defines a novel signaling pathway in cell migration, J Cell Biol,2005,169:789-799.
[7]Stenphen L,Ellson C,Hawkins P.Role of leukocyte chemotaxis and phagocytosis[J].Curr Opin Cell Biol,2002,14(2):202-213.
[8]苏君梅.Akt与肿瘤的关系及其作用机制的研究进展.杭州师范学院学报(医学版),2008,28(4)：272-274.
[9]Sale EM, Hodgkinsen CP, Jones NP, et al.A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNKIand ATP citrate lyase[J].Biochemistry,2006,45(1):213-223.
[10]Osaki M, Oshimura M, Ito H.PDK/Akt pathway:its functions and alterations in human cancer. Apoptasis,2004,9(6):667-676.
[11]Edwards LA,Thiessen B,Dragnwska WH,et al.Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth Oncogene,2005,24(22):3596-3605.
[12]Song G,Ouyang G, Bac S. The activation of Akt/PKB signaling pathway and cell survival[J]. J Cell Mol Med,2005,9(1):59-71.
[13]Reedquist KA, Ludikhuize J, Tak PP. Phosphoinositide 3-kinase signalling and FoxO transcrip tion factors in rheumatoid arthritis. Biochem Soc Trans.2006;34:727-730.
[14]Zhang HG, Wang Y, Xie JF, Liang X, Liu D, Yang P, et al.Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt.Arthritis Rheum 2001;44(7):1555-1567.
[15]Morel J, Audo R, Hahne M, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem.2005;280(16):15709-15718.
[16]Kim G, Jun JB, Elkon KB.Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibro blasts.Arthritis Rheum.2002;46(6):1504-1511.
[17]Pap T, Franz JK, Hummel KM, et al. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res.2000;2(1):59-64
[18]Niquet J, Wasterlain CGBim, Bad, and Bax:a deadly combination in epileptic seizures[J]. J Clin Invest,2004,113(7):960-962.
[19]Xin M, Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphory lation[J].J Biol Chem,2005,280(11):10781-10789.
[20]Birkenkamp KU, Coffer PJ. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J Immunol 2003; 171(4):1623-1629.
[21]Vandermcere F,EI Yazidi,Belkoura I et al.The antiapoptotic effect of fibroblast growth factor-2 is mediated though nuclear factor-kappaB activation induced via interaction between Akt and IKappaB kinase-beta in breast cancer cells[J]. Oncogene,2005,24(35):5482-5491.
[22]Li Q, Verma IM.NF-kappaB regulation in the immune system, Nat Rev. Immunol.2002(2): 725-734.
[23]Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt)pathway in cell cycle progression, Cell Cycle,2003,2:339-345.
[24]Foijer F, Riele H. Check, double check:the G2 barrier to cancer, Cell Cycle 2006,5:831-836.
[25]Montecucco F, Steffens S, Burger F,et al. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1 alpha) on human neutrophils through defined signalling pathways. Cell Signal.2008;20(3):557-68.
[26]Ferrandi C, Ardissone V, Ferro P, et al. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther.2007,322(3):923-930.
[27]Sasaki, T, Irie-Sasaki, J, Jones, R.G, et al. Function of PI3K7 in thymocyte development, T cell activation, and neutrophil migration. Science 2000,287,1040-1046.
[28]Li Z, Jiang H, Xie W, et al.. Roles of PLC-β2 and-β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science,2000:287,1046-1049.
[29]Hirsch E, Katanaev VL, Garlanda C,et al. Central role for G protein-coupled phosphoinositide 3-kinase in inflammation. Science 2000,287,1049-1053.
[30]Camps M, Ruckle T, Ji H, et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med.2005,11,936-943.
[31]Randis TM, Puri KD, Zhou H,et al. Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils. Eur J Immunol.2008,38,1215-1224.
[32]Jones GE, Prigmore E, Calvez R, et al. Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1, Exp Cell Res 2003,290:120-131.
[33]Prete AD, Vermi W, Dander E,et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice, EMBO J.2004,23:3505-3515.
[34]Laffargue M, Calvez R, Finan P, et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function, Immunity,2002,16:441-451.
[35]Kim KW, Cho ML, Park MK,et al. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther.2005; 7(1):R139-148.
[36]Choi YA, Lim HK, Kim JR, et al. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem.2004,27; 279(35):36579-36585.
[37]Foey A, Green P, Foxwell B,et al. Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K:implications for rheumatoid arthritis.Arthritis Res.2002; 4(1):64-70.
[38]Wang K, Scheel-Toellner D,et al. Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta, and NF-kappa B signaling pathways. J Immunol.2003;15;171(2):1035-1041.
[39]Wenink MH, Santegoets KC, Roelofs MF, et al.The inhibitory Fc gamma Ⅱb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.J Immunol.2009, 1;183(7):4509-4520.
[40]Chiu YC, Lin CY, Chen CP,et al. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway.J Immunol. 2009 Aug 15;183(4):2785-2792.
[41]Westra J, Brouwer E, Bos R, et al.Regulation of cytokine-induced HIF-lalpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci.2007;1108:340-348.
[42]Yoo JK, Kwon H, Khil LY, et al.IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways.J Immunol. 2005,175(12):8280-8286.
[43]Forough R,WeylieB,Collins C, et al. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo:role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.J Vase Res.2006; 43(4):327-337.
[44]王聪华,陈丽娜,朱平等.CD147分子通过VEGF促进类风湿关节炎滑膜组织中的血管新生.细胞与分子免疫学杂志,2007,23(5)：426-428.
[45]Tan SY, Xiao L, Pi X,et al. Aberrant Gi protein coupled receptor-mediated cell survival signaling in rheumatoid arthritis B cell lines.Front Biosci.2007, 1;12:1651-1660.
[46]Hofseth LJ. Husaain SP, Wogan GN。 et al. Nitric oxide in cancer and Chemopmvention[J]. Free Radic Biol Med,2003,34(8):955-968.
[47]Ruhul Amin AR, Senga T, et al.Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta:a role for the dual signalling pathways, Akt and Erk Genes Cells.2003;8 (6):515-523.
[48]Park CM,Park MJ.Kwak HJ, etal. Ionizing radiation enbancemmtfix metalloproteinase-2 secretion and invasion of glioma cells through src/epidennal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways[J].Cancer Res,2006,66(17): 8511-8519.
[49]Hayer S, Pundt N, Peters MA, etal.PI3K(?)regulates cartilage damage in chronic inflammatory arthritis,The FASEB Journal.2009;23:4288-4298.
[50]Wu T, Mohan C. The AKT axis as a therapeutic target in autoimmune diseases.Endocr Metab Immune Disord Drug Targets.2009;9(2):145-150.
[51]Miyashita T,Kawakami A,Tamai M, et al. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoprosis inducing ligand mediated apoptosis in rheumatoid synovial cells. Biochem Biophys Res Commun,2003,312 (2):397-404.
[52]Dhaouadi T, Sfar I, Abelmoula L,et al.Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review.Tunis Med. 2007;85(12):991-998.
[53]Wang CR, Shiau AL, Chen SY, et al. Amelioration of collagen-induced arthritis in rats by adenovirus-mediated PTEN gene transfer.Arthritis Rheum.2008;58(6):1650-1656.
[54]Ameriks MK, Venable JD. Small molecule inhibitors of phosphoinositide 3-kinase (PI3K) delta and gamma.Curr Top Med Chem.2009;9(8):738-753.
[55]Stein RC, Waterfield MD. PI3-kinase inhibition:a target for drug development? Mol Med Today 2000; 6(9):347-357.
[56]Sadhu C, Dick K, Tino WT, Staunton DE. Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun 2003; 308(4):764-769.
[57]Sadhu C, Masinovsky B, Dick K, Sowell CG, Staunton DE.Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 2003; 170(5):2647-2654.
[58]Sawyer C, Sturge J, Bennett DC, O'Hare MJ, Allen WE, Bain J, etal. Regulation of breast cancer cell chemotaxis by thephosphoinositide 3-kinase p110delta. Cancer Res 2003; 63(7):1667-1675.
[59]Reedquist KA,LudikhuizeJ,Tak PP.Phosphoinositide3-kinase signalling and FoxO transcription factors in rheumatoid arthritis. Biochem Soc Trans.2006; 34(5):727-730.